WO2002070734A1 - Method for determining concentration of an analyte in a test strip - Google Patents

Method for determining concentration of an analyte in a test strip Download PDF

Info

Publication number
WO2002070734A1
WO2002070734A1 PCT/US2002/003415 US0203415W WO02070734A1 WO 2002070734 A1 WO2002070734 A1 WO 2002070734A1 US 0203415 W US0203415 W US 0203415W WO 02070734 A1 WO02070734 A1 WO 02070734A1
Authority
WO
WIPO (PCT)
Prior art keywords
measuring
fluid sample
value
analyte
final
Prior art date
Application number
PCT/US2002/003415
Other languages
French (fr)
Inventor
Brent E. Modzelewski
Steven B. Gilmour
G. Thomas Roth
Douglas E. Bell
Original Assignee
Home Diagnostics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Home Diagnostics, Inc. filed Critical Home Diagnostics, Inc.
Priority to EP02709363A priority Critical patent/EP1364042A4/en
Publication of WO2002070734A1 publication Critical patent/WO2002070734A1/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366Apparatus specially adapted for solid-phase testing
    • G01N33/54386Analytical elements
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/84Systems specially adapted for particular applications
    • G01N21/8483Investigating reagent band
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/14Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333Saccharide [e.g., DNA, etc.]
    • Y10T436/144444Glucose

Definitions

  • the present invention relates generally to methods of measuring the concentration of an analyte in a fluid sample. More particularly, this invention provides i methods for determining the appropriate point at which to take a measurement of an analyte concentration in a fluid sample applied to a test strip.
  • analytes such as glucose, cholesterol, intoxicants, and other constituents is frequently desirable in fluids, such as blood, plasma, blood serum, saliva,
  • Diabetics suffer from an impaired ability to regulate glucose levels in their blood.
  • diabetics can have abnormally high blood sugar levels known as hyperglycemia.
  • Chronic hyperglycemia may lead to long-term complications such as cardiovascular disease and degeneration of the kidneys, retinas, blood vessels and the nervous system.
  • diabetics must strictly monitor and manage their blood
  • Reflectance based monitors comprise one category of personal, or home-use, glucose level monitoring devices. These monitors utilize an optical block which accepts test elements for photometric analysis.
  • test elements are usually in the form of test strips, which contain analytical chemistry.
  • these test strips are in the form of a disposable diagnostic test strip containing analytical chemistry upon which a fluid sample is deposited.
  • a chemical reaction occurs in the presence of a target analyte, e.g., glucose, to cause a change in the optical properties of the test strip.
  • An optical photometric device determines the analyte level of the sample by measuring an optical property, such as the intensity of reflected light at a certain wavelength from the test strip.
  • the fluid sample is usually fresh whole blood.
  • test strips for testing analytes such as glucose levels of blood samples are well known in the art and comprise various structures and materials. Test strips typically include single or multi-layered porous membrane arrangements which receive a blood sample and undergo a change in an optical property, such as a color change, in response to the interaction of blood glucose with agents/reactants in the membrane. Examples of such multi-layer strips are described in U.S. Patents 5,296,192 to Carroll and 6,010,999 to Carroll et al., the contents of both of which are incorporated herein by reference.
  • a whole blood sample Prior to reaching the reactants, a whole blood sample can be filtered to eliminate potential optical interference by removing erythrocytes, or red blood cells.
  • Some test strips operate to allow the applied blood sample to migrate to a reaction site in the membrane where the sample reacts with the agents/reactants, which is located in downstream capillary relation to the sample application site.
  • the results of the reaction are often visible as a color change at the reaction site.
  • the change may occur in invisible regions of the electromagnetic spectrum, such as infrared and ultraviolet.
  • the term "color change" will be understood to include variations in optical properties throughout the visible and invisible regions of the electromagnetic spectrum. As noted above, a color change can be correlated to the amount of glucose in the sample.
  • Home-use glucose measuring devices that use a reflectance meter to measure the color change of the test strip correlate glucose levels to the change in the amount of light reflected from the reaction site of the test strip.
  • strips can be formulated to produce a color change within a certain spectral region, and the meter designed to photometrically measure reflected, absorbed or transmitted light at a wavelength sensitive to the color change of the strip. While the present invention will be described with reference to reflectance based photometry, it would be known to one having ordinary skill in the art to apply the features of the invention to absorbance or transmittance based systems.
  • An important aspect to the accurate measurement of glucose levels in a fluid using a test strip are the methods used to calculate the glucose concentration values from the reflectance values obtained. Because different samples physically vary and will contain different levels of analyte, reaction rates and durations will vary. Prior art devices have focused on fixing an initiation point, the time from which the monitoring device begins to measure the chemical reaction of the blood sample with the test strip. This initiation point often was carefully tied to the initial contact of analyte and reagent, either manually or automatically and then the reaction was timed for a fixed period of time from this initiation point. The end point is the time at which the monitoring device takes a final reflectance reading to calculate the reported glucose level of the sample from calibration data stored in the meter's memory.
  • Some home-use glucose monitoring devices have an initiation point corresponding to manual, or user determined events. For example, some monitoring devices trigger the initiation point for measuring glucose levels upon the pressing of a button, the insertion of a test strip into the monitoring device, or upon closing an element, such as a cover or door, of the monitoring device over the test strip. These user-defined initiation points decrease the accuracy and consistency of the monitoring device because they rely on the inconsistent timing of an action by the user (i.e. insertion or covering of the test strip in the monitoring device).
  • a method for measuring an analyte in a fluid sample in a meter system comprising the steps of: a) initiating a measuring period for a fluid sample; b) measuring a property of the fluid sample at each of n points in time, said multiple points in time being spaced at predetermined intervals to form a sequence of n measurement values, where n is an integer; c) comparing two nonconsecutive measurement values to determine at least one ratio; d) terminating the measuring of the fluid sample when at least one of said at least one ratio meets predetermined criteria indicating a final analyte value can be accurately determined; and e) determining a final analyte value based on said measurement values.
  • a meter system for measuring an analyte in a fluid sample, comprising: a light intensity control circuit for measuring reflectance values of an analytic test strip onto which a fluid sample has been applied; and a processor for (a) initiating a measuring period for a fluid sample; (b) measuring the reflectance of a portion of the test strip onto which the fluid sample has been applied at each of n points in time, said multiple points in time being spaced at predetermined intervals to form a sequence of n calculated measurement values, where n is an integer; (c) comparing two nonconsecutive measurement values to determine at least one ratio; (d) terminating the reflectance measuring when at least one of said at least one ratio meets predetermined criteria indicating a final analyte value can be accurately determined; and (e) determining a final analyte value based on said measurement values; and a display for reporting said final analyte value in a user comprehensible format.
  • Fig. 1 is a perspective view of an analyte meter system according to an illustrative embodiment of the present invention
  • Fig. 2 is a test strip for receiving test fluid according to an illustrative embodiment of the present invention
  • Fig. 3 illustrates a blood test subroutine of the meter system of Fig. 1
  • Fig. 4 illustrates a representative graph of Glucose v. Time resulting from the blood test subroutine of Fig. 3;
  • Fig. 5 is a schematic representation of a meter system according to the present invention.
  • Fig. 1 depicts an analyte meter system 10 according to the present invention.
  • Meter system 10 generally includes a hand-held meter having a housing enclosure 12, power switch/button 14, up/down menu navigation button 15, menu select button 17, liquid crystal display (LCD) 18, and removable test chamber cover or shroud 16 having a test strip platform 20 for receiving and testing a multi-layered diagnostic test strip 40 for the amount of a suspected analyte, such as glucose, cholesterol, ketones, theophylline, fructosamine, and others.
  • a strip sensor (not shown) of known configuration is located at a distal end of the strip platform 20 to detect when a test strip 40 has been fully inserted into the device.
  • Fig. 2 illustrates an enlarged view of a representative diagnostic test strip 40.
  • Test strip 40 generally includes an upper and lower support layer 41 , 42, with sample receiving layers 50 located between the support layers.
  • Sample receiving layers 50 include a spreading layer 47 located adjacent upper support layer 41 , a separating layer 48, and a semi-porous membrane reagent layer 49 located adjacent lower support layer 42.
  • At least one of the sample receiving layers 50 is pretreated with a dry chemistry reagent and conditioning solution.
  • the membrane 49 and separating layer 48 are pretreated with the reagent/conditioning solution.
  • the spreading layer 47 may also be treated.
  • Each layer is positioned in substantially continuous contact with its adjacent layer as shown in Fig. 2 by adhesives and ultrasonic bonding or other known means to provide a sealed composite structure.
  • the top and bottom support layers 41 , 42 of test strip 40 each define an aperture or opening therethrough. These apertures or openings of the test strip are oriented in vertical alignment with test window of the meter (not shown) located along the strip platform, when properly positioned in meter system 10.
  • the opening in the upper support strip 41 defines a sample receiving port 44a and the opening in the lower support strip defines a reaction viewing port 44b.
  • the sample receiving layers 50 are oriented in vertical alignment with sample receiving port 44a and reaction viewing port 44b. This allows the blood sample received by the strip to pass directly from receiving port 44a to viewing port 44b.
  • test strip of Fig. 2 is illustrative only and many other test strip configurations may be used when practicing the present invention.
  • Monitoring meter system 10 of the present invention includes a circuit assembly physically and electrically connected to a printed circuit board, an example of which is schematically depicted as the block diagram of Fig. 5.
  • the circuit 100 contains a microprocessor 102 with a plurality of inputs and outputs.
  • An exemplary embodiment of the present invention uses an 8-bit device with 60K of programmable memory.
  • the microprocessor executes the meter instruction code.
  • the microprocessor receives input from the user through input device 104, which can include buttons or other input devices known in the art.
  • a display 106 and a sounder 107 or similar output devices receives data from the microprocessor for presentation to the user.
  • a memory device 108 for example EEPROM, is also connected for input from and output to the microprocessor 102.
  • a communication port 110 can also connected in input-output relationship with the microprocessor in known manner.
  • a strip sensor 112 receives a drive signal through line 114 to turn on and off photo element 116.
  • the photo element can be an LED.
  • Light from the photo element 116 is detected by the photodetector 118.
  • the photodetector can be a photodiode or phototransistor. Output from the photodetector is supplied via line 120 to the microprocessor 102.
  • the strip sensor detects when a test strip is inserted into the meter, and can be initialized by the method described in commonly assigned, copending US Patent Application 09/ , (Atty Docket 0043-00000 entitled
  • the circuit assembly can include a light intensity control circuit, represented as section 122 of the diagram, and a light detector circuit 124, discussed in further detail hereinbelow.
  • An exemplary embodiment of the present invention operates using a DC offset ("virtual ground") of 2.5V reference (not shown) and is powered from a 1.5V AAA battery (not shown), which may include a voltage divider circuit or other power management circuitry as is known in the art.
  • An analog to digital (AID) converter 126 converts analog electrical output on line 128 from the light detector circuit 124 into digital information for the microprocessor 102.
  • AID analog to digital
  • a temperature sensor 130 provides a voltage proportional to the temperature along line 132 to the A/D converter.
  • the microprocessor 102 can make a determination as to whether the temperature of the testing environment is within predetermined thresholds, and prohibit a user from running a test if accuracy would be negatively affected.
  • the light intensity control circuit (LICC) 122 will now be described.
  • the circuit is supplied by a pulse width modulated signal along line 134 from the microprocessor 102.
  • the circuit includes a low pass filter 136, a modulator 137, a flux biasing resistor 138, a reference photodiode 140, a control loop error amplifier 142, a feedback loop compensation capacitor 144, and LED drive transistors 146.
  • the LICC controls the drive supplied to the LEDs 148, as will be described.
  • the LEDs generate light, a component 150 of which will encounter the target 152, which is the test strip or other test element inserted into the meter. Another component 154 of the light strikes a chamber reflector 156 and a portion of which 158 is reflected toward reference photodiode 140.
  • One of the LEDs is a 660nm LED in the exemplary embodiment, which is appropriate for detecting glucose in a test strip marketed under the tradename PRESTIGE and sold by Home Diagnostics, Inc. of Ft. Lauderdale, FL.
  • the exemplary embodiment can be easily modified for detecting other analytes or using other strips by changing the software and LED used to obtain a different wavelength. For instance, a 580nm LED would be preferred for ketones using known analytical chemistry systems.
  • the LDC includes a main photodiode 160, a transimpedance (current to voltage) amplifier 162, a high pass filter 164, an amplifier 166, and a negative gain amplifier 168.
  • the output stage of the exemplary LDC includes a demodulator 170, a level shifting amplifier 172, and a low pass filter 174.
  • the output stage provides a DC voltage to line 128, as set forth above.
  • the LDC supplies an analog signal to the A/D converter, which when digitized is interpreted by the microprocessor to provide test results.
  • input to the A/D converter is conventionally multiplexed, receiving input from lines 128 and 132, and from other signal lines not shown and not necessary to understand the present invention.
  • two LEDs are employed, at 610 nm and 660 nm as described herein.
  • the LEDs are selected according to the instruction code at appropriate times by the microprocessor 102 by a signal sent via line 176, which activates a switch 178. If additional LEDs are employed, then additional signal lines and switches can be added in conventional manner. The selection between the two LEDs in the exemplary embodiment is the subject of commonly assigned copending US
  • Patent Application 09/ (Atty Docket 0008-00000 entitled "Distinguishing Test
  • a pulse width signal is produced by the microprocessor 102 along line 134.
  • the pulse width modulation signal is basically a 2.5V signal delivered either on or off according to a duty cycle.
  • the duty cycle is 50%, so that the signal is 50% on, and 50% off. Accordingly, when the signal is on, it is delivered at 2.5 volts and when it's off, it is zero volts.
  • the signal in line 134 is averaged by the low pass filter 136 to arrive at a drive voltage for the LEDs, which will in turn determine their output. For example, for a perfect 2.5V square wave, the average voltage, and thus the output of the low pass filter 136 will be 1.25V. In this way, the power delivered to the LEDs can be modified by the microprocessor by changing the duty cycle of the pulse width modulation signal. To increase the light power, the duty cycle of the signal would be increased.
  • the duty cycle of the pulse width modulation signal is determined during factory calibration of the meter, and the duty cycle value is permanently stored in the EEPROM.
  • periodic calibration routines known in the art could also be employed.
  • different LEDs may have different preferred drive requirements, so different duty cycles can be utilized based on the LED in operation.
  • the circuit 100 employes a modulation or "chopping" function controlled by the microprocessor 102.
  • the microprocessor 102 supplies a modulation signal via line 180 to the modulator 137 of the LICC and to the demodulator 170 of the LDC in synchrony.
  • the chopping signal is essentially a square wave (on/off) signal supplied to drive the LEDs at a certain frequency, rather than at constant power, to eliminate noise in the signal output of the circuit. In the exemplary embodiment, a 2 kHz chop is employed.
  • the chopping function allows the shifting of the frequency of the light signals LICC upward to a "quieter" region of the spectrum where ambient light effects can be minimized in the LDC.
  • incandescent lights have a frequency of 120 Hz. Fluorescent lights are also 120 Hz, but also have harmonic frequencies. By shifting the drive frequency of the LEDs above that of ambient light at the LICC, the LDC will be able to receive a signal at the matching frequency that is above the spectrum where most noise is encountered.
  • the LICC includes flux biasing resistor 138 which is in parallel with modulator 137.
  • This resistor in parallel essentially inhibits the voltage from the low pass filter 136 from being completely turned off by the modulator 137.
  • the chopping function instead of modulating between full-on to full-off will modulate between full-on and low.
  • the LEDs will be either full-on or dim, but never completely off.
  • This positive bias helps to compensate for this tendency toward ground and allows the circuit to adapt without a change in peak-to-peak amplitude by keeping the modulated signal above ground.
  • the control loop amplifier 142 in connection with the compensation capacitor 144 receives the output from the reference photodiode 140 to provide a feedback mechanism in determining the appropriate drive power for the LEDs 148.
  • reflected light 153 is received by the main photodiode 160, producing a photocurrent based on the reflectance.
  • the photocurrent output of the photodiode 160 is supplied to transimpedance amplifier 162, which converts the photocurrent to a voltage.
  • This voltage is conditioned by high pass filter 164, which removes noise components of the signal below the chopping frequency. It is here that the noise components of artificial lighting are filtered out, although certain harmonics of fluorescent light are eliminated after demodulation by low pass filter 174.
  • a 400 Hz cutoff frequency is employed in high pass filter 164.
  • the signal emerging from high pass filter 164 is basically a square wave voltage at the chopping frequency that is nominally .5V peak-peak maximum and centered about the vitual ground of 2.5V.
  • amplifier 166 and negative gain amplifier 168 are employed as follows. When the LED is on, the top half of the square wave is connected by level shifting amplifier 172; and when the LED is off, the bottom half of the square wave is amplified by minus unity and connected by level shifting amplifier 172. This inverts the bottom half of the square wave when the LED is off.
  • the demodulator 170 selects between the amplifiers 166, 168 in synchrony with the modulation occurring in the LIDC at modulator 137.
  • the resulting signal emerging from demodulator 170 is a DC signal proportional to the reflectance of the chemistry, in relation to the 2.5V reference voltage in the exemplary embodiment.
  • Level shifting amplifier 172 receives the DC signal from the demodulator 170, applies a gain and shifts the signal to a range acceptable to the A/D converter, which in the exemplary embodiment is approximately 2.6V maximum.
  • Low pass filter 174 removes spiking introduced by the demodulation of the signal by amplifiers 166, 168, and also removes a large amount of the harmonics of artificial light that were shifted high by the demodulation. Further, Any DC offsets in the amplifier stages prior to the demodulations that were shifted up to the chopping frequency are also effectively filtered. The only noise left in the signal are harmonics of ambient light that are right around the chopping frequency, which in the exemplary embodiment of 2 kHz are minimal.
  • the chop frequency is 2048 HZ, which is more conveniently generated by binary digital systems than 2000Hz, the strongest remaining interfering harmonic will be 8 Hz (
  • ). Since this interfering signal is of known frequency, it can be further reduced by simple synchronous digital filtering techniques. In countries that use 50Hz power grids, the strongest interfering frequency will be 2 Hz (the 25 th harmonic of 100Hz 2050Hz,
  • 2Hz). A simple synchronous digital filtering technique that "nulls- out" both 2Hz and 8Hz can be implemented.
  • the microprocessor and code of instructions perform the calculations to arrive at the ultimate reported glucose measurement. It should be noted, however, that similar calculations can be used for deriving the amount of other analytes found in the fluid sample applied to the test strip so long as meter system 10 has been properly configured and calibrated for the particular test (analyte/reagent pair, etc.) of interest.
  • the equations used for determining the glucose level calculations derived from Kubelka-Munk, are listed below. The first calculation is the K/S calculation and is as follows:
  • the K/S value which compares light absorbed to light scattered, is directly related to the percentage of reflectance (R) measured by the light detector(s) as calculated by the microprocessor.
  • the K/S calculation is then used to determine the glucose value in a linear equation.
  • the glucose calculation is determined as follows:
  • the instruction code includes a plurality of routines for operating meter system 10.
  • the aspects of meter software include but are not limited to: meter power-up, system diagnostics, meter readying, meter calibration, reflectance and optics calibration, code curve calibration, strip sensor calibration, temperature calibration, the blood test algorithm, test strip code management, test results storage and recall, standard strip test management, operational mode management, and user preferences setup.
  • the operational aspects of the software discussed above can be in any conventional format.
  • the blood test algorithm discussed below is initiated immediately upon the insertion of a test strip upon which fluid containing the analyte of interest has already been placed, and a reaction already underway.
  • the insertion of a test strip 40 into the platform 20 trips a strip sensor 112 as shown in Fig. 5 which comprises a phototransistor or photodiode that initiates the blood test algorithm.
  • the strip insertion can be detected as described in commonly assigned copending patent application
  • the blood test algorithm is illustrated in Fig. 3 and includes steps 100 through 138.
  • the code curve parameters are obtained at step 102.
  • the code curves are calibration values stored in the memory of the device to account for slight lot-to-lot variations that occur due to strip manufacturing and processing.
  • the subroutine then provides a check to determine whether a period of time, for example 80 seconds, have elapsed without completing the blood test procedure and arriving at a final value for glucose, or whether the strip has been removed from test strip platform, or shroud 20. If this termination period of e.g. 80 seconds has elapsed, or the test strip has been removed, an error is indicated and the meter system powers down (steps 104-108 of Fig. 3).
  • the next step in the blood test algorithm includes performing an intermediate glucose reading and saving the results thereof in an intermediate glucose buffer (110, 112).
  • the subroutine determines whether 6 or more glucose reading have occurred (114). If 6 readings have not occurred, the system waits the remainder of one second from the previous reading and checks again whether the termination period has expired, and whether the strip is still in the shroud 20 (steps 116, 104, 108). If the termination period has not elapsed and the test strip is still in place, a second reading of the test strip is performed and the glucose intermediate value is calculated and stored. This sequence continues until six or more readings are stored in the intermediate glucose buffer. These intermediate glucose values are values obtained by the glucose calculation, but may not represent the actual glucose concentration of the sample if the reaction has not stabilized.
  • a ratio of the sixth glucose value to the first glucose value is calculated at step 118. If this ratio is greater than 1.025, then another, seventh glucose value is obtained as set forth in steps 104-116 described above (120, 122). With the seventh glucose value obtained, a ratio of the seventh glucose value to the second glucose value is calculated. If again the ratio is greater than 1.025, then another, eighth glucose value is measured. This process continues with the glucose measurements taken at periodic intervals, and a ratio of the (n) lh to the (n-5) th reading is calculated after each glucose value is determined, where "n" corresponds to the number of readings that have taken place.
  • measurements can be taken at one second intervals, thus, "n" can correspond to both the number of measurements and, after the sixth measurement is taken, the number of seconds since insertion of an already reacted strip into the meter system.
  • the successive ratio calculations are illustrated in the Glucose v. Time graph of Fig. 4. On the graph, time is depicted on the x-axis with values from glucose in mg/dl reported on the y-axis. Representative glucose values beginning 20 seconds after the insertion of an already reacting strip into the meter system are depicted.
  • a ratio is calculated comparing the value obtained for glucose, or 258 mg/dL, to the value obtained at (25 - 5), or 20 seconds, which is 249 mg/dL.
  • the calculated ratio of these two glucose values is 1.036.
  • the ratio of the glucose value obtained at 31 seconds as compared to at (31 - 5), or 26 seconds is equal to 1.019, which is less than 1.025.
  • the next ratio calculated (at 27 seconds), as seen across the top border of the graph is 1.027.
  • Two consecutive ratios must be calculated as being less than 1.025 in order for the meter to report a final glucose value.
  • the calculated ratio is less than 1.025, resulting from the comparison at the glucose value obtained at 34 seconds to that obtained at (34 - 5), or 29 seconds, resulting in a ratio of 1.023.
  • the next calculated ratio, at arrow "C”, is 1.023, satisfying the condition that two consecutive calculated ratios are less than 1.025.
  • the final value for glucose calculated by the meter can be that obtained at arrow C, at 35 seconds, or 271 mg/dL.
  • the glucose testing end point is presumed to have been reached and the testing is deemed complete.
  • the final calculated glucose value is then converted to the appropriate units and reference type and displayed on the LCD (steps 130, 138).
  • the final calculated glucose value is the value calculated at time (n) of the second ratio that was calculated to be less than or equal to 1.025. A long, audible beep can be sounded and the final glucose value displayed, or further processing may occur as discussed below.
  • meter system 10 can check if battery voltage is sufficient, and can check if the ambient light is acceptable (steps 132, 134). If ambient light levels are not acceptable at either the reflectance or the reference detector, an error message can be displayed, and the final glucose reading is not displayed and the system is powered down (134). These tests can be performed initially or periodically and need not be performed only at the end of the test.
  • the final glucose value displayed to the user can be obtained by averaging the second glucose values (n) from each of the ratios found to be less than or equal to the value of 1.025.
  • the value reported to the user can be calculated from an extrapolation into the future based on the slope of line connecting the two final glucose values averaged in the previous example.
  • the slope connecting the readings of 270 and 271 mg/dL, or 1 mg/dL/s can be used to extrapolate glucose values into the future. Because the ratio condition of 1.025 is met two consecutive times, the reaction kinetics have practically slowed nearly to the actual theoretical end point of the reaction, and the slope of this predictive line will be relatively flat. Prediction into the future using the glucose values at arrows B and C can be employed to accurately extrapolate a final reported measurement without having to wait for reflectance measurements to be taken.
  • a negative slope can also indicate that a fully reacted test strip has been inserted, and the decreasing glucose values calculated by the algorithm after full reaction could be the result of various phenomena, for example by the formation of late reaction products.
  • managing negative slope conditions allows the meter in accordance with the present invention to exclude from testing fully reacted test strips, and avoids reporting potentially erroneous results to the user.
  • the meter can signal an error condition and abort the test. If negative slope is not persistently observed and only occurs at the very end of the testing period, a negative slope can be avoided by correcting the condition contributing to the negative slope before any extrapolation.
  • the meter can predict for a zero slope in these instances, in which case the extrapolated value would be equal to the final calculated glucose value.
  • Other techniques can also be employed. For linear extrapolation, two sequential calculated glucose values used in the extrapolation can be averaged to arrive at a positive or zero slope, or the value statistically determined in a known manner to be most likely in error excluded. The second derivative of the calculated glucose values can also be employed.
  • monitoring meter system 10 may include a memory for storing successive final glucose values.
  • the memory may hold a collection of successive final glucose values, such as, for example, 365 values. With the capacity of modern subminiature memory chips, a very large amount of data can be reliably stored. These final values can be recalled by pressing a control button 15.
  • meter system 10 may include a data port or a modem assembly for downloading the stored final glucose values to another computer system.
  • the computer system receiving the downloaded final glucose values could be a home PC, or that of a doctor, or a website operator, or any other person or organization for providing assistance to the user in monitoring their glucose levels, or for collecting data on diabetes management on a community regional national or international basis.
  • Trie modem assembly can be of any configuration (e.g.
  • TCP/IP or ATM TCP/IP or ATM
  • wireless communication capabilities e.g. those using GSM, WAP, CDMA, etc.
  • GSM Global System for Mobile communications
  • WAP Wireless Fidelity
  • CDMA Code Division Multiple Access
  • One such modem is described in copending commonly- assigned US Patent Application No. 09/512,9 9, filed February 25, 2000, the contents of which are hereby incorporated by reference.
  • Other embodiments of the invention will be apparent to those skilled in the art from consideration of the specification and practice of the invention disclosed herein. It is intended that the specification and examples be considered as illustrative only, with a true scope and spirit of the invention being indicated by the following claims.

Abstract

The present invention provides a method of measuring an analyte, such a glucose in a fluid sample, such as whole blood, by a reflectance reading device (Figure 1). The method includes making periodic intermediate calculations of analyte level and dynamically ascertaining when an analytical reaction has reached an end point. Once stable, the process stops making periodic calculations and reports the final, actual glucose concentration. According to an exemplary embodiment, the method is performed by a reflectance photometer (10) using an analytical test strip (40) containing reagents that react with an analyte of interest in the test fluid. The end point is determined by calculating an intermediate analyte level of the testing element at predetermined intervals and calculating a ratio value corresponding to the (n)th measurement to an (n-5)th measurement. When two consecutive ratio values are less than or equal to a predetermined value, the end point is deemed reached and the final analyte level ascertained.

Description

DESCRIPTION OF THE INVENTION
METHOD FOR DETERMINING CONCENTRATION OF AN ANALYTE IN A TEST STRIP
Field of the Invention
The present invention relates generally to methods of measuring the concentration of an analyte in a fluid sample. More particularly, this invention provides i methods for determining the appropriate point at which to take a measurement of an analyte concentration in a fluid sample applied to a test strip.
Background of the Invention
Monitoring analytes such as glucose, cholesterol, intoxicants, and other constituents is frequently desirable in fluids, such as blood, plasma, blood serum, saliva,
) urine, and other biological fluids. In healthcare applications, such monitoring affords the opportunity to make rapid diagnoses of a patient's condition and to take prophylactic or therapeutic measures necessary for maintaining proper health.
One such healthcare application that has benefited tremendously by analyte monitoring in recent years is the treatment of diabetes. Diabetics suffer from an impaired ability to regulate glucose levels in their blood. As a result, diabetics can have abnormally high blood sugar levels known as hyperglycemia. Chronic hyperglycemia may lead to long-term complications such as cardiovascular disease and degeneration of the kidneys, retinas, blood vessels and the nervous system. To minimize the risk of such long term complications, diabetics must strictly monitor and manage their blood
0 glucose levels. Diabetics that have glucose levels that fluctuate several times throughout the day require very close blood glucose level monitoring. Close monitoring of blood glucose levels is most easily obtained when a diabetic is able to monitor their glucose levels themselves. Many devices currently available allow diabetics to measure their own blood sugar levels.
Reflectance:based monitors comprise one category of personal, or home-use, glucose level monitoring devices. These monitors utilize an optical block which accepts test elements for photometric analysis.
The test elements are usually in the form of test strips, which contain analytical chemistry. Conventionally, these test strips are in the form of a disposable diagnostic test strip containing analytical chemistry upon which a fluid sample is deposited. Once the user applies the fluid sample to the test strip, and the sample has sufficiently penetrated the test strip, a chemical reaction occurs in the presence of a target analyte, e.g., glucose, to cause a change in the optical properties of the test strip. An optical photometric device then determines the analyte level of the sample by measuring an optical property, such as the intensity of reflected light at a certain wavelength from the test strip. For in vitro analysis in "healthcare applications, the fluid sample is usually fresh whole blood. Periodically, however, it is desirable to run a test on a test element formed by applying a control solution of known analyte concentration to a test strip, in order to verify that the meter is performing within operational limits. It is also desirable for the user to insert a "standard strip", which is a test element that has known optical properties, in order to verify that the meter is operating within operational limits. Diagnostic test strips for testing analytes such as glucose levels of blood samples are well known in the art and comprise various structures and materials. Test strips typically include single or multi-layered porous membrane arrangements which receive a blood sample and undergo a change in an optical property, such as a color change, in response to the interaction of blood glucose with agents/reactants in the membrane. Examples of such multi-layer strips are described in U.S. Patents 5,296,192 to Carroll and 6,010,999 to Carroll et al., the contents of both of which are incorporated herein by reference.
Prior to reaching the reactants, a whole blood sample can be filtered to eliminate potential optical interference by removing erythrocytes, or red blood cells. Some test strips operate to allow the applied blood sample to migrate to a reaction site in the membrane where the sample reacts with the agents/reactants, which is located in downstream capillary relation to the sample application site. The results of the reaction are often visible as a color change at the reaction site. However, the change may occur in invisible regions of the electromagnetic spectrum, such as infrared and ultraviolet. For the purposes of this application, the term "color change" will be understood to include variations in optical properties throughout the visible and invisible regions of the electromagnetic spectrum. As noted above, a color change can be correlated to the amount of glucose in the sample. Home-use glucose measuring devices that use a reflectance meter to measure the color change of the test strip correlate glucose levels to the change in the amount of light reflected from the reaction site of the test strip. As is well known in the art, strips can be formulated to produce a color change within a certain spectral region, and the meter designed to photometrically measure reflected, absorbed or transmitted light at a wavelength sensitive to the color change of the strip. While the present invention will be described with reference to reflectance based photometry, it would be known to one having ordinary skill in the art to apply the features of the invention to absorbance or transmittance based systems.
An important aspect to the accurate measurement of glucose levels in a fluid using a test strip are the methods used to calculate the glucose concentration values from the reflectance values obtained. Because different samples physically vary and will contain different levels of analyte, reaction rates and durations will vary. Prior art devices have focused on fixing an initiation point, the time from which the monitoring device begins to measure the chemical reaction of the blood sample with the test strip. This initiation point often was carefully tied to the initial contact of analyte and reagent, either manually or automatically and then the reaction was timed for a fixed period of time from this initiation point. The end point is the time at which the monitoring device takes a final reflectance reading to calculate the reported glucose level of the sample from calibration data stored in the meter's memory. Because a fixed time (or times) is used in the prior art, calibration is simplified, but this approach requires waiting for a fixed period. The fixed time period is usually longer than required for the reaction to complete, resulting in user inconvenience. Some home-use glucose monitoring devices have an initiation point corresponding to manual, or user determined events. For example, some monitoring devices trigger the initiation point for measuring glucose levels upon the pressing of a button, the insertion of a test strip into the monitoring device, or upon closing an element, such as a cover or door, of the monitoring device over the test strip. These user-defined initiation points decrease the accuracy and consistency of the monitoring device because they rely on the inconsistent timing of an action by the user (i.e. insertion or covering of the test strip in the monitoring device). These inaccuracies in determining the initiation point are commonly carried through to the end point measurement time. This results from the fact that many common monitoring devices use a fixed time period from the initiation point to determine when to initiate the end point measurement. This fixed period timing is especially problematic when using multi- layer test strips because of the nonuniform absorption periods inherent with such test strips, owing to physical differences between various samples (e.g. hematocrit, sample viscosity as well as general operational conditions such as temperature, humidity, etc.).
Accordingly, conventional methods for determining initiation and end points for measuring glucose levels from test strips may yield inaccurate results because the methods depend on events or time periods unrelated to the reaction kinetics of the blood sample and the test strip. Further, because reactions each occur at different rates, reliance on a fixed time period between an initiation point and the end point may prolong the measuring time beyond the time necessary to accurately measure the glucose level of the sample, resulting in user inconvenience. While a more accurate measuring time may only yield a few seconds improvement over a fixed measuring time, such an improvement is substantial to the person who uses a device multiple times daily. Further, a more accurate, uncomplicated and quick method for testing blood samples for glucose levels will encourage patients to monitor their blood sugar levels more regularly, thereby promoting compliance with their prescribed regimens for diabetes management.
It is accordingly a primary object of the invention to provide a method for rapid and accurate methods for determining an analyte concentration in a fluid sample.
SUMMARY OF THE INVENTION
In accordance with the invention, a method is disclosed for measuring an analyte in a fluid sample in a meter system, comprising the steps of: a) initiating a measuring period for a fluid sample; b) measuring a property of the fluid sample at each of n points in time, said multiple points in time being spaced at predetermined intervals to form a sequence of n measurement values, where n is an integer; c) comparing two nonconsecutive measurement values to determine at least one ratio; d) terminating the measuring of the fluid sample when at least one of said at least one ratio meets predetermined criteria indicating a final analyte value can be accurately determined; and e) determining a final analyte value based on said measurement values.
In further accordance with the invention, a meter system is disclosed for measuring an analyte in a fluid sample, comprising: a light intensity control circuit for measuring reflectance values of an analytic test strip onto which a fluid sample has been applied; and a processor for (a) initiating a measuring period for a fluid sample; (b) measuring the reflectance of a portion of the test strip onto which the fluid sample has been applied at each of n points in time, said multiple points in time being spaced at predetermined intervals to form a sequence of n calculated measurement values, where n is an integer; (c) comparing two nonconsecutive measurement values to determine at least one ratio; (d) terminating the reflectance measuring when at least one of said at least one ratio meets predetermined criteria indicating a final analyte value can be accurately determined; and (e) determining a final analyte value based on said measurement values; and a display for reporting said final analyte value in a user comprehensible format.
Additional objects and advantages of the invention will be set forth in part in the description which follows, and in part will be obvious from the description, or may be learned by practice of the invention. The objects and advantages of the invention will be realized and attained by means of the elements and combinations particularly pointed out in the appended claims.
It is to be understood that both the foregoing general description and the following detailed description are exemplary and explanatory only and are not restrictive of the invention, as claimed.
BRIEF DESCRIPTION OF THE DRAWINGS
The accompanying drawings, which are incorporated in and constitute a part of this specification, describe an illustrative embodiment of the invention and together with the description, serve to explain the principles of the invention.
Fig. 1 is a perspective view of an analyte meter system according to an illustrative embodiment of the present invention;
Fig. 2 is a test strip for receiving test fluid according to an illustrative embodiment of the present invention; Fig. 3 illustrates a blood test subroutine of the meter system of Fig. 1 ; Fig. 4 illustrates a representative graph of Glucose v. Time resulting from the blood test subroutine of Fig. 3; and
Fig. 5 is a schematic representation of a meter system according to the present invention.
DESCRIPTION OF AN ILLUSTRATIVE EMBODIMENT
Reference will now be made in detail to an illustrative embodiment of the invention, an example of which appears in the accompanying drawings. Wherever possible, the same reference numbers will be used throughout the drawings to refer to the same or like parts.
With reference to the drawings, Fig. 1 depicts an analyte meter system 10 according to the present invention. Meter system 10 generally includes a hand-held meter having a housing enclosure 12, power switch/button 14, up/down menu navigation button 15, menu select button 17, liquid crystal display (LCD) 18, and removable test chamber cover or shroud 16 having a test strip platform 20 for receiving and testing a multi-layered diagnostic test strip 40 for the amount of a suspected analyte, such as glucose, cholesterol, ketones, theophylline, fructosamine, and others. A strip sensor (not shown) of known configuration is located at a distal end of the strip platform 20 to detect when a test strip 40 has been fully inserted into the device. Although the discussion is directed herein to an illustrative embodiment of monitoring glucose levels in whole blood samples for purposes of describing the instant invention, one having ordinary skill in the art will appreciate that the present invention is adaptable for testing any of a plurality of analytes.
Fig. 2 illustrates an enlarged view of a representative diagnostic test strip 40. Test strip 40 generally includes an upper and lower support layer 41 , 42, with sample receiving layers 50 located between the support layers. Sample receiving layers 50 include a spreading layer 47 located adjacent upper support layer 41 , a separating layer 48, and a semi-porous membrane reagent layer 49 located adjacent lower support layer 42. At least one of the sample receiving layers 50 is pretreated with a dry chemistry reagent and conditioning solution. Preferably, the membrane 49 and separating layer 48 are pretreated with the reagent/conditioning solution. The spreading layer 47 may also be treated. Each layer is positioned in substantially continuous contact with its adjacent layer as shown in Fig. 2 by adhesives and ultrasonic bonding or other known means to provide a sealed composite structure.
The top and bottom support layers 41 , 42 of test strip 40 each define an aperture or opening therethrough. These apertures or openings of the test strip are oriented in vertical alignment with test window of the meter (not shown) located along the strip platform, when properly positioned in meter system 10. The opening in the upper support strip 41 defines a sample receiving port 44a and the opening in the lower support strip defines a reaction viewing port 44b. The sample receiving layers 50 are oriented in vertical alignment with sample receiving port 44a and reaction viewing port 44b. This allows the blood sample received by the strip to pass directly from receiving port 44a to viewing port 44b. As the sample travels to the viewing port 44b it will encounter reagent, and any analyte in the sample will begin to react with the reagent and begin to form a detectable condition, such as a color change. This detectable condition is assessed from the viewing port and can be used to determine the presence of, or to calculate the concentration of an analyte of interest. The test strip of Fig. 2 is illustrative only and many other test strip configurations may be used when practicing the present invention.
Monitoring meter system 10 of the present invention includes a circuit assembly physically and electrically connected to a printed circuit board, an example of which is schematically depicted as the block diagram of Fig. 5. The circuit 100 contains a microprocessor 102 with a plurality of inputs and outputs. An exemplary embodiment of the present invention uses an 8-bit device with 60K of programmable memory. The microprocessor executes the meter instruction code. The microprocessor receives input from the user through input device 104, which can include buttons or other input devices known in the art. A display 106 and a sounder 107 or similar output devices receives data from the microprocessor for presentation to the user. A memory device 108, for example EEPROM, is also connected for input from and output to the microprocessor 102. A communication port 110 can also connected in input-output relationship with the microprocessor in known manner.
A strip sensor 112 receives a drive signal through line 114 to turn on and off photo element 116. The photo element can be an LED. Light from the photo element 116 is detected by the photodetector 118. The photodetector can be a photodiode or phototransistor. Output from the photodetector is supplied via line 120 to the microprocessor 102. The strip sensor detects when a test strip is inserted into the meter, and can be initialized by the method described in commonly assigned, copending US Patent Application 09/ , (Atty Docket 0043-00000 entitled
"Improved Method of Strip Insertion Detection"), filed concurrently herewith, the contents of which are incorporated herein by reference.
The circuit assembly can include a light intensity control circuit, represented as section 122 of the diagram, and a light detector circuit 124, discussed in further detail hereinbelow. An exemplary embodiment of the present invention operates using a DC offset ("virtual ground") of 2.5V reference (not shown) and is powered from a 1.5V AAA battery (not shown), which may include a voltage divider circuit or other power management circuitry as is known in the art.
An analog to digital (AID) converter 126 converts analog electrical output on line 128 from the light detector circuit 124 into digital information for the microprocessor 102. In an exemplary embodiment of the invention, a 12-bit A/D converter is employed. A temperature sensor 130 provides a voltage proportional to the temperature along line 132 to the A/D converter. The microprocessor 102 can make a determination as to whether the temperature of the testing environment is within predetermined thresholds, and prohibit a user from running a test if accuracy would be negatively affected.
The light intensity control circuit (LICC) 122 will now be described. In an exemplary embodiment, the circuit is supplied by a pulse width modulated signal along line 134 from the microprocessor 102. The circuit includes a low pass filter 136, a modulator 137, a flux biasing resistor 138, a reference photodiode 140, a control loop error amplifier 142, a feedback loop compensation capacitor 144, and LED drive transistors 146. The LICC controls the drive supplied to the LEDs 148, as will be described.
The LEDs, of which there are two in the exemplary embodiment, generate light, a component 150 of which will encounter the target 152, which is the test strip or other test element inserted into the meter. Another component 154 of the light strikes a chamber reflector 156 and a portion of which 158 is reflected toward reference photodiode 140. One of the LEDs is a 660nm LED in the exemplary embodiment, which is appropriate for detecting glucose in a test strip marketed under the tradename PRESTIGE and sold by Home Diagnostics, Inc. of Ft. Lauderdale, FL. The exemplary embodiment can be easily modified for detecting other analytes or using other strips by changing the software and LED used to obtain a different wavelength. For instance, a 580nm LED would be preferred for ketones using known analytical chemistry systems.
The light detector circuit (LDC) 124 will now be described. In an exemplary embodiment, the LDC includes a main photodiode 160, a transimpedance (current to voltage) amplifier 162, a high pass filter 164, an amplifier 166, and a negative gain amplifier 168. The output stage of the exemplary LDC includes a demodulator 170, a level shifting amplifier 172, and a low pass filter 174. The output stage provides a DC voltage to line 128, as set forth above. The LDC supplies an analog signal to the A/D converter, which when digitized is interpreted by the microprocessor to provide test results.
In the exemplary embodiment, input to the A/D converter is conventionally multiplexed, receiving input from lines 128 and 132, and from other signal lines not shown and not necessary to understand the present invention.
In the exemplary embodiment, two LEDs are employed, at 610 nm and 660 nm as described herein. The LEDs are selected according to the instruction code at appropriate times by the microprocessor 102 by a signal sent via line 176, which activates a switch 178. If additional LEDs are employed, then additional signal lines and switches can be added in conventional manner. The selection between the two LEDs in the exemplary embodiment is the subject of commonly assigned copending US
Patent Application 09/ , (Atty Docket 0008-00000 entitled "Distinguishing Test
Types Through Spectral Analysis"), filed concurrently herewith, the contents of which are incorporated herein by reference.
The operation of the exemplary circuit 100 will now be described. A pulse width signal is produced by the microprocessor 102 along line 134. As is well known, the pulse width modulation signal is basically a 2.5V signal delivered either on or off according to a duty cycle. In a perfect square wave, the duty cycle is 50%, so that the signal is 50% on, and 50% off. Accordingly, when the signal is on, it is delivered at 2.5 volts and when it's off, it is zero volts. The signal in line 134 is averaged by the low pass filter 136 to arrive at a drive voltage for the LEDs, which will in turn determine their output. For example, for a perfect 2.5V square wave, the average voltage, and thus the output of the low pass filter 136 will be 1.25V. In this way, the power delivered to the LEDs can be modified by the microprocessor by changing the duty cycle of the pulse width modulation signal. To increase the light power, the duty cycle of the signal would be increased.
In the exemplary embodiment, the duty cycle of the pulse width modulation signal is determined during factory calibration of the meter, and the duty cycle value is permanently stored in the EEPROM. Of course, periodic calibration routines known in the art could also be employed. Further, different LEDs may have different preferred drive requirements, so different duty cycles can be utilized based on the LED in operation.
The circuit 100 employes a modulation or "chopping" function controlled by the microprocessor 102. The microprocessor 102 supplies a modulation signal via line 180 to the modulator 137 of the LICC and to the demodulator 170 of the LDC in synchrony. The chopping signal is essentially a square wave (on/off) signal supplied to drive the LEDs at a certain frequency, rather than at constant power, to eliminate noise in the signal output of the circuit. In the exemplary embodiment, a 2 kHz chop is employed. The chopping function allows the shifting of the frequency of the light signals LICC upward to a "quieter" region of the spectrum where ambient light effects can be minimized in the LDC. For example, while sunlight is 0 Hz (DC), incandescent lights have a frequency of 120 Hz. Fluorescent lights are also 120 Hz, but also have harmonic frequencies. By shifting the drive frequency of the LEDs above that of ambient light at the LICC, the LDC will be able to receive a signal at the matching frequency that is above the spectrum where most noise is encountered.
The LICC includes flux biasing resistor 138 which is in parallel with modulator 137. This resistor in parallel essentially inhibits the voltage from the low pass filter 136 from being completely turned off by the modulator 137. In this way, the chopping function, instead of modulating between full-on to full-off will modulate between full-on and low. The result is that the LEDs will be either full-on or dim, but never completely off. Several benefits are realized by this arrangement. First, because the LEDs are never dark, a positive bias is always present at the reference diode 140. As a result, when interfering ambient light reaches the reference diode 140, there is a tendency for the modulated signal to move toward ground. This positive bias helps to compensate for this tendency toward ground and allows the circuit to adapt without a change in peak-to-peak amplitude by keeping the modulated signal above ground. Second, the fact that a voltage is always present maintains control loop error amplifier 142 further above ground, which promotes better performance.
The control loop amplifier 142, in connection with the compensation capacitor 144 receives the output from the reference photodiode 140 to provide a feedback mechanism in determining the appropriate drive power for the LEDs 148. '
When target 152 is illuminated by light 150 from an LED 148, reflected light 153 is received by the main photodiode 160, producing a photocurrent based on the reflectance. The photocurrent output of the photodiode 160 is supplied to transimpedance amplifier 162, which converts the photocurrent to a voltage. This voltage is conditioned by high pass filter 164, which removes noise components of the signal below the chopping frequency. It is here that the noise components of artificial lighting are filtered out, although certain harmonics of fluorescent light are eliminated after demodulation by low pass filter 174. In the exemplary embodiment, a 400 Hz cutoff frequency is employed in high pass filter 164.
The signal emerging from high pass filter 164 is basically a square wave voltage at the chopping frequency that is nominally .5V peak-peak maximum and centered about the vitual ground of 2.5V. To condition the output for the A/D converter, which in the exemplary embodiment operates at approximately 2.6V maximum, amplifier 166 and negative gain amplifier 168 are employed as follows. When the LED is on, the top half of the square wave is connected by level shifting amplifier 172; and when the LED is off, the bottom half of the square wave is amplified by minus unity and connected by level shifting amplifier 172. This inverts the bottom half of the square wave when the LED is off. The demodulator 170 selects between the amplifiers 166, 168 in synchrony with the modulation occurring in the LIDC at modulator 137. The resulting signal emerging from demodulator 170 is a DC signal proportional to the reflectance of the chemistry, in relation to the 2.5V reference voltage in the exemplary embodiment.
Level shifting amplifier 172, a differential amplifier, receives the DC signal from the demodulator 170, applies a gain and shifts the signal to a range acceptable to the A/D converter, which in the exemplary embodiment is approximately 2.6V maximum. Low pass filter 174 removes spiking introduced by the demodulation of the signal by amplifiers 166, 168, and also removes a large amount of the harmonics of artificial light that were shifted high by the demodulation. Further, Any DC offsets in the amplifier stages prior to the demodulations that were shifted up to the chopping frequency are also effectively filtered. The only noise left in the signal are harmonics of ambient light that are right around the chopping frequency, which in the exemplary embodiment of 2 kHz are minimal.
These remaining harmonics are of known frequency and their relationship to the chop frequency will determine their frequency. For example, the 17th harmonic of fluorescent lighting will be 120Hz x 17 = 2040 Hz. If the chop frequency is 2048 HZ, which is more conveniently generated by binary digital systems than 2000Hz, the strongest remaining interfering harmonic will be 8 Hz ( |2048Hz - 2040Hz| ). Since this interfering signal is of known frequency, it can be further reduced by simple synchronous digital filtering techniques. In countries that use 50Hz power grids, the strongest interfering frequency will be 2 Hz (the 25th harmonic of 100Hz = 2050Hz, |2048Hz - 2050Hz| = 2Hz). A simple synchronous digital filtering technique that "nulls- out" both 2Hz and 8Hz can be implemented.
The microprocessor and code of instructions perform the calculations to arrive at the ultimate reported glucose measurement. It should be noted, however, that similar calculations can be used for deriving the amount of other analytes found in the fluid sample applied to the test strip so long as meter system 10 has been properly configured and calibrated for the particular test (analyte/reagent pair, etc.) of interest. The equations used for determining the glucose level calculations derived from Kubelka-Munk, are listed below. The first calculation is the K/S calculation and is as follows:
K (1-R)2
S 2R
(1) K/S calculation
As shown by the equation, the K/S value, which compares light absorbed to light scattered, is directly related to the percentage of reflectance (R) measured by the light detector(s) as calculated by the microprocessor. The K/S calculation is then used to determine the glucose value in a linear equation. The glucose calculation is determined as follows:
K Glucose = m + b
S
(2) Glucose calculation As can be seen by the second calculation, glucose is dependent on (K/S), the slope m and intercept b.
The instruction code includes a plurality of routines for operating meter system 10. The aspects of meter software include but are not limited to: meter power-up, system diagnostics, meter readying, meter calibration, reflectance and optics calibration, code curve calibration, strip sensor calibration, temperature calibration, the blood test algorithm, test strip code management, test results storage and recall, standard strip test management, operational mode management, and user preferences setup. With the exception of the blood test algorithm detailed below, the operational aspects of the software discussed above can be in any conventional format.
The blood test algorithm discussed below is initiated immediately upon the insertion of a test strip upon which fluid containing the analyte of interest has already been placed, and a reaction already underway. The insertion of a test strip 40 into the platform 20 trips a strip sensor 112 as shown in Fig. 5 which comprises a phototransistor or photodiode that initiates the blood test algorithm. The strip insertion can be detected as described in commonly assigned copending patent application
Serial No. 09/ , , (Atty Docket No. 0043-00000 entitled "Improved Method of
Strip Insertion Detection") filed concurrently herewith, the contents of which are incorporated herein by reference.
The blood test algorithm is illustrated in Fig. 3 and includes steps 100 through 138. Once a glucose intermediate buffer and "ratio ok" flag is cleared, the code curve parameters are obtained at step 102. The code curves are calibration values stored in the memory of the device to account for slight lot-to-lot variations that occur due to strip manufacturing and processing. The subroutine then provides a check to determine whether a period of time, for example 80 seconds, have elapsed without completing the blood test procedure and arriving at a final value for glucose, or whether the strip has been removed from test strip platform, or shroud 20. If this termination period of e.g. 80 seconds has elapsed, or the test strip has been removed, an error is indicated and the meter system powers down (steps 104-108 of Fig. 3).
The next step in the blood test algorithm includes performing an intermediate glucose reading and saving the results thereof in an intermediate glucose buffer (110, 112). The subroutine then determines whether 6 or more glucose reading have occurred (114). If 6 readings have not occurred, the system waits the remainder of one second from the previous reading and checks again whether the termination period has expired, and whether the strip is still in the shroud 20 (steps 116, 104, 108). If the termination period has not elapsed and the test strip is still in place, a second reading of the test strip is performed and the glucose intermediate value is calculated and stored. This sequence continues until six or more readings are stored in the intermediate glucose buffer. These intermediate glucose values are values obtained by the glucose calculation, but may not represent the actual glucose concentration of the sample if the reaction has not stabilized. Indeed, only the last several calculated glucose values approach the actual concentration as the reaction stabilizes, as will be described below. Once six glucose values have been obtained, a ratio of the sixth glucose value to the first glucose value is calculated at step 118. If this ratio is greater than 1.025, then another, seventh glucose value is obtained as set forth in steps 104-116 described above (120, 122). With the seventh glucose value obtained, a ratio of the seventh glucose value to the second glucose value is calculated. If again the ratio is greater than 1.025, then another, eighth glucose value is measured. This process continues with the glucose measurements taken at periodic intervals, and a ratio of the (n)lh to the (n-5)th reading is calculated after each glucose value is determined, where "n" corresponds to the number of readings that have taken place. According to an embodiment of the invention, measurements can be taken at one second intervals, thus, "n" can correspond to both the number of measurements and, after the sixth measurement is taken, the number of seconds since insertion of an already reacted strip into the meter system. The successive ratio calculations are illustrated in the Glucose v. Time graph of Fig. 4. On the graph, time is depicted on the x-axis with values from glucose in mg/dl reported on the y-axis. Representative glucose values beginning 20 seconds after the insertion of an already reacting strip into the meter system are depicted. As shown at the sixth measurement on the graph, at 25 seconds, a ratio is calculated comparing the value obtained for glucose, or 258 mg/dL, to the value obtained at (25 - 5), or 20 seconds, which is 249 mg/dL. As depicted across the top boarder of the graph, the calculated ratio of these two glucose values is 1.036. As shown by arrow A in the figure, at 31 seconds, the ratio of the glucose value obtained at 31 seconds as compared to at (31 - 5), or 26 seconds, is equal to 1.019, which is less than 1.025. However, the next ratio calculated (at 27 seconds), as seen across the top border of the graph, is 1.027. Two consecutive ratios must be calculated as being less than 1.025 in order for the meter to report a final glucose value. As indicated by arrow B in the graph, once again the calculated ratio is less than 1.025, resulting from the comparison at the glucose value obtained at 34 seconds to that obtained at (34 - 5), or 29 seconds, resulting in a ratio of 1.023. The next calculated ratio, at arrow "C", is 1.023, satisfying the condition that two consecutive calculated ratios are less than 1.025. At this point, the final value for glucose calculated by the meter can be that obtained at arrow C, at 35 seconds, or 271 mg/dL.
When two consecutive ratios are calculated to be equal to or less than 1.025, the glucose testing end point is presumed to have been reached and the testing is deemed complete. The final calculated glucose value is then converted to the appropriate units and reference type and displayed on the LCD (steps 130, 138). The final calculated glucose value is the value calculated at time (n) of the second ratio that was calculated to be less than or equal to 1.025. A long, audible beep can be sounded and the final glucose value displayed, or further processing may occur as discussed below.
Before displaying the final glucose value, meter system 10 can check if battery voltage is sufficient, and can check if the ambient light is acceptable (steps 132, 134). If ambient light levels are not acceptable at either the reflectance or the reference detector, an error message can be displayed, and the final glucose reading is not displayed and the system is powered down (134). These tests can be performed initially or periodically and need not be performed only at the end of the test.
In an alternative embodiment of the present invention, the final glucose value displayed to the user can be obtained by averaging the second glucose values (n) from each of the ratios found to be less than or equal to the value of 1.025. Using this method for determining the final glucose value with the data of the chart of Fig. 4, the final glucose value would be the average of the glucose values at arrows "B" and "C," or (270+ 271 )/2 = 270.5 mg/dL, which would in practice be rounded up or down to an integer value.
In a further alternative embodiment, the value reported to the user can be calculated from an extrapolation into the future based on the slope of line connecting the two final glucose values averaged in the previous example. In this way, the slope connecting the readings of 270 and 271 mg/dL, or 1 mg/dL/s, can be used to extrapolate glucose values into the future. Because the ratio condition of 1.025 is met two consecutive times, the reaction kinetics have practically slowed nearly to the actual theoretical end point of the reaction, and the slope of this predictive line will be relatively flat. Prediction into the future using the glucose values at arrows B and C can be employed to accurately extrapolate a final reported measurement without having to wait for reflectance measurements to be taken. In some instances, for example for particular reaction kinetics or for certain calibration code lots, it may be desirable to include a predictive element to the calculation algorithm. This prediction is also practical for tuning average statistical meter performance over time to prior art meters, allowing users of older meters to continue to utilize historical data with new data without introducing statistical error. While calculating the slope from two values is a simple method to include in extrapolating values, other known mathematical methods can be employed. For example, three or more points can be used and linear regression employed to fit a curve, or a calculation of the second derivative of the reaction curve, or a portion thereof, can also be employed. Polynomial extrapolation or curve-fitting can also be used. As shown in Fig. 4, the curve of calculated intermediate glucose values follows an upward trend, that is, has a positive slope. This should be true until the final measurements and before any extrapolation or curve fitting takes place, because the final ratio value of 1.025 is still 2.5% higher than for a perfectly flat curve, which would have a ratio value of 1.000. However, it is desirable that a negative slope is not used to predict a future glucose value. Because a persistent or significant negative slope will not normally occur during reaction measurement, the occurrence of such a negative slope could be the result of variations in meter reflectance measurements, or noise. Extrapolation using a negative slope would therefore include components of noise and undesirably impact accuracy.
A negative slope can also indicate that a fully reacted test strip has been inserted, and the decreasing glucose values calculated by the algorithm after full reaction could be the result of various phenomena, for example by the formation of late reaction products. Advantageously, managing negative slope conditions allows the meter in accordance with the present invention to exclude from testing fully reacted test strips, and avoids reporting potentially erroneous results to the user. By monitoring the ratio calculations, repetitive occurrences of ratios below 1.000, or a second derivative calculated as negative over a number of readings, the meter can signal an error condition and abort the test. If negative slope is not persistently observed and only occurs at the very end of the testing period, a negative slope can be avoided by correcting the condition contributing to the negative slope before any extrapolation. Essentially, the meter can predict for a zero slope in these instances, in which case the extrapolated value would be equal to the final calculated glucose value. Other techniques can also be employed. For linear extrapolation, two sequential calculated glucose values used in the extrapolation can be averaged to arrive at a positive or zero slope, or the value statistically determined in a known manner to be most likely in error excluded. The second derivative of the calculated glucose values can also be employed.
Finally, monitoring meter system 10 may include a memory for storing successive final glucose values. The memory may hold a collection of successive final glucose values, such as, for example, 365 values. With the capacity of modern subminiature memory chips, a very large amount of data can be reliably stored. These final values can be recalled by pressing a control button 15. Further, meter system 10 may include a data port or a modem assembly for downloading the stored final glucose values to another computer system. The computer system receiving the downloaded final glucose values could be a home PC, or that of a doctor, or a website operator, or any other person or organization for providing assistance to the user in monitoring their glucose levels, or for collecting data on diabetes management on a community regional national or international basis. Trie modem assembly can be of any configuration (e.g. TCP/IP or ATM), or those having wireless communication capabilities (e.g. those using GSM, WAP, CDMA, etc.). One such modem is described in copending commonly- assigned US Patent Application No. 09/512,9 9, filed February 25, 2000, the contents of which are hereby incorporated by reference. Other embodiments of the invention will be apparent to those skilled in the art from consideration of the specification and practice of the invention disclosed herein. It is intended that the specification and examples be considered as illustrative only, with a true scope and spirit of the invention being indicated by the following claims.

Claims

WE CLAIM:
1. A method for measuring an analyte in a fluid sample in a meter system, comprising: initiating a measuring period for a fluid sample; measuring a property of the fluid sample at each of n points in time, said points in time being spaced at predetermined intervals to form a sequence of n measurement values, where n is an integer; comparing two nonconsecutive measurement values to determine at least one ratio; terminating the measuring of the fluid sample when at least one of said at least one ratio meets predetermined criteria indicating a final analyte value can be accurately determined; and determining a final analyte value based on said measurement values.
2. The method for measuring an analyte in a fluid sample according to claim 1 , wherein the step of measuring comprises measuring a property of an analytic test strip onto which said fluid sample has been applied.
3. The method for measuring an analyte in a fluid sample according to claim 2, wherein the analyte being measured is glucose.
4. The method for measuring an analyte in a fluid sample according to claim 2, wherein said measuring step further comprises the step of measuring a reflectance value of a test strip onto which said fluid sample has been applied.
5. The method for measuring an analyte in a fluid sample according to claim 4, wherein said predetermined intervals are each about one second in duration.
6. The method for measuring an analyte in a fluid sample according to claim 4, wherein n > 6 and said two nonconsecutive measurement values correspond to the
nth measurement value and the (n-5)th measurement value, wherein the ratio is calculated by dividing the nth measurement value by the (n-δ)1*1 measurement value.
7. The method for measuring an analyte in a fluid sample according to claim 6, wherein said at least one of said at least one ratio in said terminating step comprises two consecutive ratios.
8. The method for measuring an analyte in a fluid sample according to claim 7, wherein said predetermined criteria corresponds to a calculated ratio value of less than or equal to a predetermined value.
9. The method for measuring an analyte in a fluid sample according to claim 8, wherein said predetermined value is 1.025.
10. The method for measuring an analyte in a fluid sample according to claim 7, wherein the determining step includes calculating a final glucose value from a final measurement value obtained before terminating the measuring.
11. The method for measuring an analyte in a fluid sample according to claim 7, wherein the determining step includes calculating a final glucose value from an average of the numerators of each of said two consecutive ratios meeting the predetermined criteria.
12. The method for measuring an analyte in a fluid sample according to claim 7, wherein the determining step further comprises the step of extrapolating.
13. The method for measuring an analyte in a fluid sample according to claim 2, wherein said initiation step is triggered by proper insertion of the test strip in the meter system.
14. A meter system for measuring an analyte in a fluid sample, comprising: a light intensity control circuit for measuring reflectance values of an analytic test strip onto which a fluid sample has been applied; and a processor for
(a) initiating a measuring period for a fluid sample;
(b) measuring the reflectance of a portion of the test strip onto which the fluid sample has been applied at each of n points in time, said multiple points in time being spaced at predetermined intervals to form a sequence of n calculated measurement values, where n is an integer;
(c) comparing two nonconsecutive measurement values to determine at least one ratio,
(d) terminating the reflectance measuring when at least one of said at least one ratio meets predetermined criteria indicating a final analyte value can be accurately determined; and
(e) determining a final analyte value based on said measurement values; and a display for reporting said final analyte value in a user comprehensible format.
15. The meter system according to claim 14, wherein said analyte is glucose.
16. The meter system according to claim 15, wherein said predetermined intervals are each one second in duration.
17. The meter system according to claim 15, wherein n > 6 and said two
nonconsecutive measurement values correspond to the nth measurement value and the (n-δ)"1 measurement value, wherein the ratio is calculated by dividing the nth measurement value by the (n-5)th measurement value.
18. The meter system according to claim 17, wherein said at least one of said at least one ratio comprises two consecutive ratios.
19. The meter system according to claim 18, wherein said predetermined criteria corresponds to a calculated ratio value of less than or equal to a predetermined value.
20. The meter system according to claim 19, wherein said predetermined value is 1.025.
21. The meter system according to claim 18, wherein the determining step includes calculating a final glucose value from a final reflectance value obtained before terminating the measuring.
22. The meter system according to claim 18, wherein the determining step includes calculating a final glucose value from an average of the nth reflectance values of each of said two consecutive ratios meeting the predetermined criteria.
23. The meter system according to claim 14, further including a strip sensor for determining whether a test strip has been properly inserted in the meter system, wherein the initiation function of the processor is triggered by the strip sensor.
24. The meter system according to claim 14, wherein said processor determines the final analyte value based on an extrapolation of the measurement values.
25. The method for measuring an analyte in a fluid sample in a meter system according to claim 1 , wherein said step of determining a final analyte value further comprises extrapolating from the measurement values.
26. A method for measuring the concentration of glucose in a biological fluid sample in a meter system, comprising: initiating a measuring period for a biological fluid sample; measuring a property of the fluid sample at each of n points in time, said multiple points in time being spaced at predetermined intervals to form a sequence of n measurement values, where n is an integer and greater than 2; comparing two nonconsecutive measurement values to determine at least one
ratio; terminating the measuring of the biological fluid sample when at least one of said at least one ratio meets predetermined criteria indicating a final glucose concentration value can be accurately determined; and determining a final glucose concentration value based on said measurement values.
27. The method for measuring glucose concentration in a biological fluid sample according to claim 26, wherein the step of measuring comprises measuring an analytic test strip onto which said fluid sample has been applied.
28. The method for measuring glucose concentration in a biological fluid sample according to claim 27, wherein said measuring step further comprises the step of measuring a reflectance value of the test strip onto which said fluid sample has been applied.
29. The method for measuring glucose concentration in a biological fluid sample according to claim 28, wherein said predetermined intervals are each one second in duration.
30. The method for measuring glucose concentration in a biological fluid sample according to claim 28, wherein n > 6 and said two nonconsecutive measurement
values correspond to the nth measurement value and the (n-5)th measurement value, wherein the ratio is calculated by dividing the nth measurement value by the (n-5)th measurement value.
31. The method for measuring glucose concentration in a biological fluid sample according to claim 30, wherein said at least one of said at least one ratio in said terminating step comprises two consecutive ratios.
32. The method for measuring glucose concentration in a biological fluid sample according to claim 31 , wherein said predetermined criteria corresponds to a calculated ratio value of less than or equal to a predetermined value.
33. The method for measuring glucose concentration in a biological fluid sample according to claim 32, wherein said predetermined value is 1.025.
34. The method for measuring glucose concentration in a biological fluid sample according to claim 31, wherein the determining step includes calculating a final glucose value from a final measurement value obtained before terminating the measuring.
35. The method for measuring glucose concentration in a biological fluid sample according to claim 31 , wherein the determining step includes calculating a final glucose value from an average of the nth measurement values of each of said two consecutive ratios meeting the predetermined criteria.
36. The method for measuring glucose concentration in a biological fluid sample according to claim 27, wherein said initiation step is triggered by proper insertion of the test strip in the meter system.
PCT/US2002/003415 2001-02-28 2002-02-28 Method for determining concentration of an analyte in a test strip WO2002070734A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP02709363A EP1364042A4 (en) 2001-02-28 2002-02-28 Method for determining concentration of an analyte in a test strip

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/794,045 2001-02-28
US09/794,045 US6541266B2 (en) 2001-02-28 2001-02-28 Method for determining concentration of an analyte in a test strip

Publications (1)

Publication Number Publication Date
WO2002070734A1 true WO2002070734A1 (en) 2002-09-12

Family

ID=25161518

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/003415 WO2002070734A1 (en) 2001-02-28 2002-02-28 Method for determining concentration of an analyte in a test strip

Country Status (3)

Country Link
US (1) US6541266B2 (en)
EP (1) EP1364042A4 (en)
WO (1) WO2002070734A1 (en)

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1452854A1 (en) * 2001-11-20 2004-09-01 Arkray, Inc. Fail judging method for analysis and analyzer
WO2008017819A1 (en) * 2006-08-08 2008-02-14 Ivmd (Uk) Limited Assay apparatus, assay reading apparatus and method
WO2009101242A1 (en) * 2008-02-14 2009-08-20 Orion Diagnostica Oy Method for predicting a future property
US7645373B2 (en) 2003-06-20 2010-01-12 Roche Diagnostic Operations, Inc. System and method for coding information on a biosensor test strip
US7645421B2 (en) 2003-06-20 2010-01-12 Roche Diagnostics Operations, Inc. System and method for coding information on a biosensor test strip
US7718439B2 (en) 2003-06-20 2010-05-18 Roche Diagnostics Operations, Inc. System and method for coding information on a biosensor test strip
US7727467B2 (en) 2003-06-20 2010-06-01 Roche Diagnostics Operations, Inc. Reagent stripe for test strip
US8058077B2 (en) 2003-06-20 2011-11-15 Roche Diagnostics Operations, Inc. Method for coding information on a biosensor test strip
US8071030B2 (en) 2003-06-20 2011-12-06 Roche Diagnostics Operations, Inc. Test strip with flared sample receiving chamber
US8206565B2 (en) 2003-06-20 2012-06-26 Roche Diagnostics Operation, Inc. System and method for coding information on a biosensor test strip
US8287703B2 (en) 1999-10-04 2012-10-16 Roche Diagnostics Operations, Inc. Biosensor and method of making
US8298828B2 (en) 2003-06-20 2012-10-30 Roche Diagnostics Operations, Inc. System and method for determining the concentration of an analyte in a sample fluid
US8663442B2 (en) 2003-06-20 2014-03-04 Roche Diagnostics Operations, Inc. System and method for analyte measurement using dose sufficiency electrodes
US9410915B2 (en) 2004-06-18 2016-08-09 Roche Operations Ltd. System and method for quality assurance of a biosensor test strip
US9885712B2 (en) 2012-11-15 2018-02-06 Ortho-Clinical Diagnostics, Inc. Calibrating assays using reaction time
EP3315069A1 (en) * 2016-10-25 2018-05-02 Roche Diabetes Care GmbH Method for determination of an analyte concentration in a body fluid and analyte concentration measurement device

Families Citing this family (189)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6036924A (en) 1997-12-04 2000-03-14 Hewlett-Packard Company Cassette of lancet cartridges for sampling blood
US8071384B2 (en) 1997-12-22 2011-12-06 Roche Diagnostics Operations, Inc. Control and calibration solutions and methods for their use
US6391005B1 (en) 1998-03-30 2002-05-21 Agilent Technologies, Inc. Apparatus and method for penetration with shaft having a sensor for sensing penetration depth
US6290646B1 (en) 1999-04-16 2001-09-18 Cardiocom Apparatus and method for monitoring and communicating wellness parameters of ambulatory patients
US8419650B2 (en) 1999-04-16 2013-04-16 Cariocom, LLC Downloadable datasets for a patient monitoring system
DE19952215C2 (en) * 1999-10-29 2001-10-31 Roche Diagnostics Gmbh Test element analysis system
US8641644B2 (en) 2000-11-21 2014-02-04 Sanofi-Aventis Deutschland Gmbh Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means
US7041068B2 (en) 2001-06-12 2006-05-09 Pelikan Technologies, Inc. Sampling module device and method
CA2448902C (en) 2001-06-12 2010-09-07 Pelikan Technologies, Inc. Self optimizing lancing device with adaptation means to temporal variations in cutaneous properties
US9226699B2 (en) 2002-04-19 2016-01-05 Sanofi-Aventis Deutschland Gmbh Body fluid sampling module with a continuous compression tissue interface surface
WO2002100254A2 (en) 2001-06-12 2002-12-19 Pelikan Technologies, Inc. Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge
EP1395185B1 (en) 2001-06-12 2010-10-27 Pelikan Technologies Inc. Electric lancet actuator
ES2357887T3 (en) 2001-06-12 2011-05-03 Pelikan Technologies Inc. APPARATUS FOR IMPROVING THE BLOOD OBTAINING SUCCESS RATE FROM A CAPILLARY PUNCTURE.
US7344507B2 (en) 2002-04-19 2008-03-18 Pelikan Technologies, Inc. Method and apparatus for lancet actuation
US8337419B2 (en) 2002-04-19 2012-12-25 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US9795747B2 (en) 2010-06-02 2017-10-24 Sanofi-Aventis Deutschland Gmbh Methods and apparatus for lancet actuation
US7981056B2 (en) 2002-04-19 2011-07-19 Pelikan Technologies, Inc. Methods and apparatus for lancet actuation
US9427532B2 (en) 2001-06-12 2016-08-30 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US7682318B2 (en) 2001-06-12 2010-03-23 Pelikan Technologies, Inc. Blood sampling apparatus and method
US6989891B2 (en) * 2001-11-08 2006-01-24 Optiscan Biomedical Corporation Device and method for in vitro determination of analyte concentrations within body fluids
US6997343B2 (en) 2001-11-14 2006-02-14 Hypoguard Limited Sensor dispensing device
EP1448489B1 (en) * 2001-11-16 2010-08-25 Stefan Ufer Flexible sensor and method of fabrication
DE10156809B4 (en) * 2001-11-20 2011-06-16 Lre Technology Partner Gmbh Method and device for blood glucose measurement
AU2002346662A1 (en) * 2001-12-04 2003-06-17 Euregen Llc Methods and compositions for selectively cleaving dna containing duplex acids in a complex nucleic acid mixture
US20030111357A1 (en) * 2001-12-13 2003-06-19 Black Murdo M. Test meter calibration
US9247901B2 (en) 2003-08-22 2016-02-02 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US8260393B2 (en) 2003-07-25 2012-09-04 Dexcom, Inc. Systems and methods for replacing signal data artifacts in a glucose sensor data stream
US8010174B2 (en) 2003-08-22 2011-08-30 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US20030169426A1 (en) * 2002-03-08 2003-09-11 Peterson Timothy A. Test member orientation
US7491178B2 (en) 2002-04-19 2009-02-17 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7976476B2 (en) 2002-04-19 2011-07-12 Pelikan Technologies, Inc. Device and method for variable speed lancet
US8579831B2 (en) 2002-04-19 2013-11-12 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US9795334B2 (en) 2002-04-19 2017-10-24 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7297122B2 (en) 2002-04-19 2007-11-20 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7371247B2 (en) 2002-04-19 2008-05-13 Pelikan Technologies, Inc Method and apparatus for penetrating tissue
US7198606B2 (en) 2002-04-19 2007-04-03 Pelikan Technologies, Inc. Method and apparatus for a multi-use body fluid sampling device with analyte sensing
US7232451B2 (en) * 2002-04-19 2007-06-19 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7648468B2 (en) 2002-04-19 2010-01-19 Pelikon Technologies, Inc. Method and apparatus for penetrating tissue
US7229458B2 (en) 2002-04-19 2007-06-12 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7909778B2 (en) 2002-04-19 2011-03-22 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8221334B2 (en) 2002-04-19 2012-07-17 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US8267870B2 (en) 2002-04-19 2012-09-18 Sanofi-Aventis Deutschland Gmbh Method and apparatus for body fluid sampling with hybrid actuation
US7291117B2 (en) 2002-04-19 2007-11-06 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7547287B2 (en) 2002-04-19 2009-06-16 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7674232B2 (en) 2002-04-19 2010-03-09 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7892183B2 (en) 2002-04-19 2011-02-22 Pelikan Technologies, Inc. Method and apparatus for body fluid sampling and analyte sensing
US7331931B2 (en) 2002-04-19 2008-02-19 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7901362B2 (en) 2002-04-19 2011-03-08 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US9314194B2 (en) 2002-04-19 2016-04-19 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US9248267B2 (en) 2002-04-19 2016-02-02 Sanofi-Aventis Deustchland Gmbh Tissue penetration device
US8784335B2 (en) 2002-04-19 2014-07-22 Sanofi-Aventis Deutschland Gmbh Body fluid sampling device with a capacitive sensor
US7717863B2 (en) 2002-04-19 2010-05-18 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8702624B2 (en) 2006-09-29 2014-04-22 Sanofi-Aventis Deutschland Gmbh Analyte measurement device with a single shot actuator
US6743635B2 (en) * 2002-04-25 2004-06-01 Home Diagnostics, Inc. System and methods for blood glucose sensing
US20080112852A1 (en) * 2002-04-25 2008-05-15 Neel Gary T Test Strips and System for Measuring Analyte Levels in a Fluid Sample
US6964871B2 (en) * 2002-04-25 2005-11-15 Home Diagnostics, Inc. Systems and methods for blood glucose sensing
US20030204313A1 (en) * 2002-04-26 2003-10-30 Yao Ou-Yang Biosensing meter
US7250095B2 (en) * 2002-07-11 2007-07-31 Hypoguard Limited Enzyme electrodes and method of manufacture
DE10248555B4 (en) * 2002-10-18 2004-12-02 Roche Diagnostics Gmbh Method and analysis system for determining the concentration of an analyte in a sample, which consists of the analyte and the sample matrix, and test element therefor
US7118916B2 (en) 2002-10-21 2006-10-10 Lifescan, Inc. Method of reducing analysis time of endpoint-type reaction profiles
US8574895B2 (en) 2002-12-30 2013-11-05 Sanofi-Aventis Deutschland Gmbh Method and apparatus using optical techniques to measure analyte levels
US7811231B2 (en) 2002-12-31 2010-10-12 Abbott Diabetes Care Inc. Continuous glucose monitoring system and methods of use
US7264139B2 (en) * 2003-01-14 2007-09-04 Hypoguard Limited Sensor dispensing device
US7379167B2 (en) * 2003-02-11 2008-05-27 International Technidyne Corporation Hemoglobin test strip and analysis system
US7587287B2 (en) 2003-04-04 2009-09-08 Abbott Diabetes Care Inc. Method and system for transferring analyte test data
ES2490740T3 (en) 2003-06-06 2014-09-04 Sanofi-Aventis Deutschland Gmbh Apparatus for blood fluid sampling and analyte detection
US8460243B2 (en) 2003-06-10 2013-06-11 Abbott Diabetes Care Inc. Glucose measuring module and insulin pump combination
US8066639B2 (en) * 2003-06-10 2011-11-29 Abbott Diabetes Care Inc. Glucose measuring device for use in personal area network
WO2006001797A1 (en) 2004-06-14 2006-01-05 Pelikan Technologies, Inc. Low pain penetrating
US8679853B2 (en) * 2003-06-20 2014-03-25 Roche Diagnostics Operations, Inc. Biosensor with laser-sealed capillary space and method of making
US7488601B2 (en) 2003-06-20 2009-02-10 Roche Diagnostic Operations, Inc. System and method for determining an abused sensor during analyte measurement
US7220034B2 (en) * 2003-07-11 2007-05-22 Rudolph Technologies, Inc. Fiber optic darkfield ring light
US7722536B2 (en) 2003-07-15 2010-05-25 Abbott Diabetes Care Inc. Glucose measuring device integrated into a holster for a personal area network device
US20190357827A1 (en) 2003-08-01 2019-11-28 Dexcom, Inc. Analyte sensor
US7591801B2 (en) 2004-02-26 2009-09-22 Dexcom, Inc. Integrated delivery device for continuous glucose sensor
US8676287B2 (en) 2003-08-01 2014-03-18 Dexcom, Inc. System and methods for processing analyte sensor data
US8845536B2 (en) 2003-08-01 2014-09-30 Dexcom, Inc. Transcutaneous analyte sensor
US8275437B2 (en) 2003-08-01 2012-09-25 Dexcom, Inc. Transcutaneous analyte sensor
US9135402B2 (en) * 2007-12-17 2015-09-15 Dexcom, Inc. Systems and methods for processing sensor data
US7774145B2 (en) 2003-08-01 2010-08-10 Dexcom, Inc. Transcutaneous analyte sensor
US6931327B2 (en) 2003-08-01 2005-08-16 Dexcom, Inc. System and methods for processing analyte sensor data
US8160669B2 (en) 2003-08-01 2012-04-17 Dexcom, Inc. Transcutaneous analyte sensor
US7519408B2 (en) 2003-11-19 2009-04-14 Dexcom, Inc. Integrated receiver for continuous analyte sensor
US7920906B2 (en) 2005-03-10 2011-04-05 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US20140121989A1 (en) 2003-08-22 2014-05-01 Dexcom, Inc. Systems and methods for processing analyte sensor data
EP1671096A4 (en) 2003-09-29 2009-09-16 Pelikan Technologies Inc Method and apparatus for an improved sample capture device
EP1680014A4 (en) 2003-10-14 2009-01-21 Pelikan Technologies Inc Method and apparatus for a variable user interface
US9247900B2 (en) 2004-07-13 2016-02-02 Dexcom, Inc. Analyte sensor
US8423114B2 (en) 2006-10-04 2013-04-16 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US8532730B2 (en) 2006-10-04 2013-09-10 Dexcom, Inc. Analyte sensor
US11633133B2 (en) 2003-12-05 2023-04-25 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
ATE480761T1 (en) 2003-12-05 2010-09-15 Dexcom Inc CALIBRATION METHODS FOR A CONTINUOUSLY WORKING ANALYTICAL SENSOR
WO2005057175A2 (en) 2003-12-09 2005-06-23 Dexcom, Inc. Signal processing for continuous analyte sensor
WO2005065414A2 (en) 2003-12-31 2005-07-21 Pelikan Technologies, Inc. Method and apparatus for improving fluidic flow and sample capture
US8147426B2 (en) 2003-12-31 2012-04-03 Nipro Diagnostics, Inc. Integrated diagnostic test system
US7822454B1 (en) 2005-01-03 2010-10-26 Pelikan Technologies, Inc. Fluid sampling device with improved analyte detecting member configuration
US20050150763A1 (en) * 2004-01-09 2005-07-14 Butters Colin W. Biosensor and method of manufacture
BRPI0507376A (en) 2004-02-06 2007-07-10 Bayer Healthcare Llc oxidizable species as an internal reference for biosensors and method of use
CA2556331A1 (en) 2004-02-17 2005-09-29 Therasense, Inc. Method and system for providing data communication in continuous glucose monitoring and management system
US8808228B2 (en) 2004-02-26 2014-08-19 Dexcom, Inc. Integrated medicament delivery device for use with continuous analyte sensor
WO2009048462A1 (en) 2007-10-09 2009-04-16 Dexcom, Inc. Integrated insulin delivery system with continuous glucose sensor
US8828203B2 (en) 2004-05-20 2014-09-09 Sanofi-Aventis Deutschland Gmbh Printable hydrogels for biosensors
WO2005120365A1 (en) 2004-06-03 2005-12-22 Pelikan Technologies, Inc. Method and apparatus for a fluid sampling device
CA3090413C (en) 2004-06-04 2023-10-10 Abbott Diabetes Care Inc. Glucose monitoring and graphical representations in a data management system
US20060002817A1 (en) * 2004-06-30 2006-01-05 Sebastian Bohm Flow modulation devices
US8343074B2 (en) 2004-06-30 2013-01-01 Lifescan Scotland Limited Fluid handling devices
US8565848B2 (en) * 2004-07-13 2013-10-22 Dexcom, Inc. Transcutaneous analyte sensor
US20060020192A1 (en) 2004-07-13 2006-01-26 Dexcom, Inc. Transcutaneous analyte sensor
US8452368B2 (en) 2004-07-13 2013-05-28 Dexcom, Inc. Transcutaneous analyte sensor
US7640048B2 (en) 2004-07-13 2009-12-29 Dexcom, Inc. Analyte sensor
US20070191716A1 (en) * 2004-09-29 2007-08-16 Daniel Goldberger Blood monitoring system
US7608042B2 (en) * 2004-09-29 2009-10-27 Intellidx, Inc. Blood monitoring system
US7224448B2 (en) * 2004-11-16 2007-05-29 Agilent Technologies, Inc. Apparatus and methods for evaluating an optical property of a liquid sample
US8652831B2 (en) 2004-12-30 2014-02-18 Sanofi-Aventis Deutschland Gmbh Method and apparatus for analyte measurement test time
US7547281B2 (en) * 2005-02-01 2009-06-16 Medtronic Minimed, Inc. Algorithm sensor augmented bolus estimator for semi-closed loop infusion system
US8112240B2 (en) 2005-04-29 2012-02-07 Abbott Diabetes Care Inc. Method and apparatus for providing leak detection in data monitoring and management systems
US8101415B2 (en) * 2005-07-05 2012-01-24 Bayer Healthcare Llc Calibration system for use with lateral flow assay test strips
US8636672B2 (en) * 2007-02-28 2014-01-28 Nipro Diagnostics, Inc. Test strip with integrated lancet
US20100081968A1 (en) * 2005-07-15 2010-04-01 Home Diagnostics, Inc. Test Strip With Integrated Lancet
ES2717135T3 (en) 2005-07-20 2019-06-19 Ascensia Diabetes Care Holdings Ag Method to signal the user to add an additional sample to a test strip, method to measure the temperature of a sample and methods to determine the concentration of an analyte based on controlled amperometry
US20070073590A1 (en) * 2005-08-22 2007-03-29 Cosentino Louis C Remote monitor for physiological parameters and durable medical supplies
US7277167B2 (en) * 2005-09-13 2007-10-02 Agilent Technologies, Inc. Modular cuvettes and methods for use thereof
KR101577176B1 (en) 2005-09-30 2015-12-14 바이엘 헬스케어 엘엘씨 Gated voltammetry analyte determination
US20070081159A1 (en) * 2005-10-11 2007-04-12 Giffin Kristin M Apparatus and methods for evaluating an optical property of a liquid sample
US7766829B2 (en) 2005-11-04 2010-08-03 Abbott Diabetes Care Inc. Method and system for providing basal profile modification in analyte monitoring and management systems
US20080200838A1 (en) * 2005-11-28 2008-08-21 Daniel Goldberger Wearable, programmable automated blood testing system
US20070123801A1 (en) * 2005-11-28 2007-05-31 Daniel Goldberger Wearable, programmable automated blood testing system
US9149215B2 (en) 2005-12-30 2015-10-06 Roche Diabetes Care, Inc. Portable analytical device
US20070152683A1 (en) * 2005-12-30 2007-07-05 Karl Werner Electronic device for analysis of a body fluid
US20070188736A1 (en) * 2006-02-16 2007-08-16 Fouquet Julie E Obtaining measurement and baseline signals for evaluating assay test strips
US7438694B2 (en) * 2006-03-07 2008-10-21 Agamatrix, Inc. Lancing device
US8226891B2 (en) 2006-03-31 2012-07-24 Abbott Diabetes Care Inc. Analyte monitoring devices and methods therefor
US8696597B2 (en) 2006-04-03 2014-04-15 Nipro Diagnostics, Inc. Diagnostic meter
US7966859B2 (en) 2006-05-03 2011-06-28 Bayer Healthcare Llc Underfill detection system for a biosensor
US8092385B2 (en) * 2006-05-23 2012-01-10 Intellidx, Inc. Fluid access interface
US8703057B2 (en) * 2006-08-08 2014-04-22 Hach Company Electronic device for analyzing aqueous solutions
KR100849942B1 (en) 2007-02-22 2008-08-01 (주)아이베이지디쓰리 Portable blood viscosity measuring device
US8123686B2 (en) 2007-03-01 2012-02-28 Abbott Diabetes Care Inc. Method and apparatus for providing rolling data in communication systems
US20080267446A1 (en) * 2007-04-18 2008-10-30 Dale Capewell Chemistry strip reader and method
US8150115B2 (en) * 2007-04-18 2012-04-03 Iris International, Inc. Chemistry strip reader and method
US8665091B2 (en) 2007-05-08 2014-03-04 Abbott Diabetes Care Inc. Method and device for determining elapsed sensor life
US20080281171A1 (en) * 2007-05-08 2008-11-13 Abbott Diabetes Care, Inc. Analyte monitoring system and methods
US7928850B2 (en) 2007-05-08 2011-04-19 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8461985B2 (en) 2007-05-08 2013-06-11 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8456301B2 (en) 2007-05-08 2013-06-04 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US20090138207A1 (en) * 2007-05-24 2009-05-28 Cosentino Daniel L Glucose meter system and monitor
US20080294024A1 (en) * 2007-05-24 2008-11-27 Cosentino Daniel L Glucose meter system and monitor
WO2008154312A1 (en) 2007-06-08 2008-12-18 Dexcom, Inc. Integrated medicament delivery device for use with continuous analyte sensor
WO2009076302A1 (en) 2007-12-10 2009-06-18 Bayer Healthcare Llc Control markers for auto-detection of control solution and methods of use
US9839395B2 (en) 2007-12-17 2017-12-12 Dexcom, Inc. Systems and methods for processing sensor data
US7766846B2 (en) * 2008-01-28 2010-08-03 Roche Diagnostics Operations, Inc. Rapid blood expression and sampling
EP2252196A4 (en) 2008-02-21 2013-05-15 Dexcom Inc Systems and methods for processing, transmitting and displaying sensor data
US20090246075A1 (en) * 2008-03-25 2009-10-01 Health & Life Co., Ltd. Biosensing device
US8241616B2 (en) * 2008-04-03 2012-08-14 Rohm And Haas Company Hair styling composition
WO2009126900A1 (en) 2008-04-11 2009-10-15 Pelikan Technologies, Inc. Method and apparatus for analyte detecting device
EP2338052B1 (en) * 2008-10-16 2019-11-20 Koninklijke Philips N.V. Method and device for determining the amount of magnetically labeled target components
US9375169B2 (en) 2009-01-30 2016-06-28 Sanofi-Aventis Deutschland Gmbh Cam drive for managing disposable penetrating member actions with a single motor and motor and control system
US8753290B2 (en) * 2009-03-27 2014-06-17 Intellectual Inspiration, Llc Fluid transfer system and method
US9226701B2 (en) 2009-04-28 2016-01-05 Abbott Diabetes Care Inc. Error detection in critical repeating data in a wireless sensor system
US20100299075A1 (en) * 2009-05-19 2010-11-25 Bayer Healthcare Llc Systems and methods for calculating an average analyte concentration value
WO2010138856A1 (en) 2009-05-29 2010-12-02 Abbott Diabetes Care Inc. Medical device antenna systems having external antenna configurations
KR101100620B1 (en) * 2009-06-04 2012-01-03 주식회사 인포피아 Apparatus and method for bio-test with algorithm for improving reproducibility
US8731638B2 (en) 2009-07-20 2014-05-20 Optiscan Biomedical Corporation Adjustable connector and dead space reduction
EP2473098A4 (en) * 2009-08-31 2014-04-09 Abbott Diabetes Care Inc Analyte signal processing device and methods
EP2473099A4 (en) 2009-08-31 2015-01-14 Abbott Diabetes Care Inc Analyte monitoring system and methods for managing power and noise
BR112012009291A2 (en) 2009-11-10 2016-05-31 Bayer Healthcare Llc underfill recognition system for a biosensor
US9949672B2 (en) 2009-12-17 2018-04-24 Ascensia Diabetes Care Holdings Ag Apparatus, systems and methods for determining and displaying pre-event and post-event analyte concentration levels
MX2012010860A (en) * 2010-03-22 2013-03-05 Bayer Healthcare Llc Residual compensation for a biosensor.
US8965476B2 (en) 2010-04-16 2015-02-24 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US9222910B2 (en) 2010-06-07 2015-12-29 Bayer Healthcare Llc Underfill management system for a biosensor
WO2012094140A1 (en) 2011-01-05 2012-07-12 Microchip Technology Incorporated Glucose measurement using a current source
US10136845B2 (en) 2011-02-28 2018-11-27 Abbott Diabetes Care Inc. Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same
TWI553097B (en) * 2011-03-11 2016-10-11 英特曼帝克司公司 Millisecond decay phosphors for ac led lighting applications
EP3575796B1 (en) 2011-04-15 2020-11-11 DexCom, Inc. Advanced analyte sensor calibration and error detection
JP5975519B2 (en) * 2011-09-07 2016-08-23 リオン株式会社 Particle size distribution measuring device by particle size and particle size distribution measuring method by particle size
EP3586831A1 (en) 2011-09-21 2020-01-01 Ascensia Diabetes Care Holdings AG Analysis compensation including segmented signals
JP6443802B2 (en) 2011-11-07 2018-12-26 アボット ダイアベティス ケア インコーポレイテッドAbbott Diabetes Care Inc. Analyte monitoring apparatus and method
WO2013112542A1 (en) 2012-01-25 2013-08-01 Intematix Corporation Long decay phosphors for lighting applications
US9528941B2 (en) 2012-08-08 2016-12-27 Scanadu Incorporated Method and apparatus for determining analyte concentration by quantifying and interpreting color information captured in a continuous or periodic manner
US9968306B2 (en) 2012-09-17 2018-05-15 Abbott Diabetes Care Inc. Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems
US9395234B2 (en) 2012-12-05 2016-07-19 Cardiocom, Llc Stabilizing base for scale
KR101750638B1 (en) 2012-12-20 2017-06-23 에프. 호프만-라 로슈 아게 Method for analyzing a sample of a body fluid
EP3008454A1 (en) 2013-06-10 2016-04-20 Roche Diagnostics GmbH Method and system for detecting an analyte in a body fluid
US9442089B2 (en) 2013-12-23 2016-09-13 Lifescan Scotland Limited Analyte meter test strip detection
WO2015134820A1 (en) * 2014-03-05 2015-09-11 Scanadu Incorporated Analyte concentration by quantifying and interpreting color
EP2916117A1 (en) * 2014-03-05 2015-09-09 Scanadu Incorporated Quantifying color changes of chemical test pads induced by specific concentrations of biological analytes under different lighting conditions
CN105044070B (en) 2015-08-18 2017-02-22 上海微银生物技术有限公司 Tear glucose detection device
US11331022B2 (en) 2017-10-24 2022-05-17 Dexcom, Inc. Pre-connected analyte sensors
CN111246797A (en) 2017-10-24 2020-06-05 德克斯康公司 Pre-attached analyte sensors

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1983000926A1 (en) * 1981-08-28 1983-03-17 Clark, Stanley Reflectance meter
US5277870A (en) * 1991-01-07 1994-01-11 United Medical Manufacturing Company Blood glucose reflectance meter including a null prompting means and a device for providing a constant brightness light
US5780304A (en) * 1994-09-08 1998-07-14 Lifescan, Inc. Method and apparatus for analyte detection having on-strip standard
US5843692A (en) * 1986-08-13 1998-12-01 Lifescan, Inc. Automatic initiation of a time interval for measuring glucose concentration in a sample of whole blood
US6040195A (en) * 1997-06-10 2000-03-21 Home Diagnostics, Inc. Diagnostic sanitary test strip
US6088608A (en) * 1997-10-20 2000-07-11 Alfred E. Mann Foundation Electrochemical sensor and integrity tests therefor
US6136610A (en) * 1998-11-23 2000-10-24 Praxsys Biosystems, Inc. Method and apparatus for performing a lateral flow assay
WO2001038859A1 (en) * 1999-11-24 2001-05-31 Home Diagnostics, Inc. Protective test strip platform for optical meter apparatus
US20020019707A1 (en) * 2000-06-26 2002-02-14 Cohen Alan M. Glucose metering system

Family Cites Families (522)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3127281A (en) 1964-03-31 Means and method of making multi-test indicator
US2369499A (en) 1945-02-13 Apparatus fob measuring rate of
US2297248A (en) 1936-08-21 1942-09-29 Rudolph Hans Porous materials and process of making
NL289920A (en) 1951-01-28
DE1598067A1 (en) 1951-01-28 1970-03-26 Boehringer Mannheim Gmbh Methods and diagnostic agents for the enzymatic determination of glucose
IT568716A (en) 1956-02-03
GB835551A (en) 1956-04-26 1960-05-25 English Electric Co Ltd Improvements in and relating to temperature measuring devices
SE173761C1 (en) 1956-11-07 1960-12-20
BE563751A (en) 1957-01-08
US3092465A (en) 1960-03-25 1963-06-04 Miles Lab Diagnostic test device for blood sugar
NL286850A (en) 1961-12-18 1900-01-01
ES310641A1 (en) 1964-03-20 1965-07-01 Boehringer & Soehne Gmbh Diagnostic agents for the detection of components contained in full blood
US3804593A (en) 1964-05-25 1974-04-16 Technicon Instr Automatic analysis apparatus and method
DE1910272U (en) 1964-11-12 1965-02-18 Boehringer & Soehne Gmbh TEST STRIP.
US3298789A (en) 1964-12-14 1967-01-17 Miles Lab Test article for the detection of glucose
GB1346301A (en) 1965-06-04 1974-02-06 Adler Auto Precision Ltd Methods for mixing and or dispensing liquids and apparatus therefor
DE1567325C3 (en) 1965-08-05 1975-06-19 Boehringer Mannheim Gmbh, 6800 Mannheim Process for the production of pure fructose and glucose from sucrose or sucrose-containing invert sugars
US3413198A (en) 1966-06-30 1968-11-26 Calbiochem Reagents and method for assaying biological samples
DE1598153C3 (en) 1966-11-22 1973-11-22 Boehringer Mannheim Gmbh, 6800 Mannheim Diagnostic means for the detection of the constituents of body fluids
US3552925A (en) 1967-07-13 1971-01-05 Miles Lab Whole blood separation method and test using same
US3552928A (en) 1967-07-19 1971-01-05 Miles Lab Whole blood separation means and test system using same
US3511608A (en) 1967-12-14 1970-05-12 Harold P Anderson Multiple layer paper test strip
US3607093A (en) 1968-02-15 1971-09-21 Schering Corp Devices for testing biological liquids
US3560161A (en) 1968-03-14 1971-02-02 Nasa Automated fluid chemical analyzer
CH482249A (en) 1968-04-19 1969-11-30 Contraves Ag Particle counting device
US3604815A (en) 1968-04-22 1971-09-14 Miles Lab Reflectance meter
US3506126A (en) 1968-05-03 1970-04-14 Milton Roy Co Closed recirculating hemodialysis system
US3591480A (en) 1968-07-15 1971-07-06 Ibm Glucose measuring system
US4066362A (en) 1968-08-16 1978-01-03 E. I. Du Pont De Nemours And Company Apparatus and method for performing photometric analysis
DE1810216B2 (en) 1968-11-21 1971-12-09 Boehnnger Mannheim GmbH, 6800 Mannheim THIN FILM CHROMATOGRAPHY DEVICE
US3593568A (en) 1969-04-01 1971-07-20 Bio Dynamics Inc Prothrombin time measuring apparatus with means to start the timer in response to the initial decrement of optical transmissivity
US3811840A (en) 1969-04-01 1974-05-21 Miles Lab Test device for detecting low concentrations of substances in fluids
DE1940816C3 (en) 1969-08-11 1974-01-17 Boehringer Mannheim Gmbh, 6800 Mannheim Method and diagnostic agent for the enzymatic determination of glucose
BE754658A (en) 1969-08-12 1971-02-10 Merck Patent Gmbh INDICATOR SHEET, CONSISTING OF AN IMPREGNATED, ABSORBENT, SHEATHED HAIR MATERIAL
DE1943580B2 (en) 1969-08-27 1971-08-05 BLOOD GLUCOSE DETECTION REAGENTS
CH513393A (en) 1969-08-28 1971-09-30 Greiner Electronic Ag Process for performing chemical and / or physical analyzes in series
US3748044A (en) 1969-09-02 1973-07-24 Abbott Lab Digital chemical analysis apparatus
DE1946137C3 (en) 1969-09-11 1975-01-02 Boehringer Mannheim Gmbh, 6800 Mannheim Process for the production of glycerol kinase from microorganisms
DE1959410C3 (en) 1969-11-26 1974-02-28 Boehringer Mannheim Gmbh, 6800 Mannheim Indicator for determining the reduced pyridine coenzymes
BE759811A (en) 1969-12-04 1971-06-03 Technicon Instr APPARATUS FOR AUTOMATIC DETERMINATION OF THE SPEEDS OF COAGULATION, AGGLUTINATION OR FLOCCULATION OF LIQUIDS, AND REACTION ENHANCING AGENT USED WITH THIS APPARATUS
US3658480A (en) 1970-04-13 1972-04-25 Bio Data Corp Coagulation timing apparatus, and method
US3690833A (en) 1970-05-04 1972-09-12 Damon Corp Automated fluids analyzer having selectively interrupted flow
US3703336A (en) 1970-06-12 1972-11-21 Instrumentation Labor Inc Analysis system employing a plural chamber cuvette structure
US3718439A (en) 1970-06-12 1973-02-27 Instrumentation Labor Inc Analytical apparatus
US3775595A (en) 1970-06-12 1973-11-27 Instrumentation Labor Inc Apparatus for processing chemical materials held in container structures
US3672845A (en) 1970-07-28 1972-06-27 Miles Lab Test device for albumin
US3672838A (en) 1970-09-10 1972-06-27 Sargent Welch Scientific Co Analytical method and apparatus using diffusion across a boundary between liquids
US3663175A (en) 1970-10-05 1972-05-16 Bio Dynamics Inc Method of determining hemoglobin in blood
US4370983A (en) 1971-01-20 1983-02-01 Lichtenstein Eric Stefan Computer-control medical care system
US3933593A (en) 1971-02-22 1976-01-20 Beckman Instruments, Inc. Rate sensing batch analysis method
US3791933A (en) 1971-02-25 1974-02-12 Geomet Rapid methods for assay of enzyme substrates and metabolites
US3709612A (en) 1971-03-10 1973-01-09 Miles Lab Apparatus for measuring reflected light under stabilized light source conditions
US3802843A (en) 1971-05-28 1974-04-09 American Hospital Supply Corp Fluid testing apparatus
DE2130287C3 (en) 1971-06-18 1975-06-05 Boehringer Mannheim Gmbh, 6800 Mannheim Method and device for introducing a metered amount of foreign liquid into a main liquid flow
CA949686A (en) 1971-07-09 1974-06-18 Her Majesty The Queen In Right Of Canada As Represented By The Minister Of National Defence Of Her Majesty's Canadian Government Data transmitting terminal
US3723064A (en) 1971-07-26 1973-03-27 L Liotta Method and device for determining the concentration of a material in a liquid
US3765841A (en) 1971-08-06 1973-10-16 Beckman Instruments Inc Method and apparatus for chemical analysis
US3795149A (en) 1971-10-15 1974-03-05 Technicon Instr Method and apparatus for supplying samples for automated analysis
US3950133A (en) 1971-10-20 1976-04-13 Mallinckrodt, Inc. Reagent formulations for assaying biological specimens and methods of preparing and using same
DE2158124C3 (en) 1971-11-24 1975-03-13 Boehringer Mannheim Gmbh, 6800 Mannheim Use of polyamide fleece or felt as an absorbent carrier for diagnostic agents
US3785772A (en) 1971-12-08 1974-01-15 Blowitz M Blood analyzer
BE793152A (en) 1971-12-22 1973-06-21 Union Carbide Corp SPECTROPHOTOMETRIC ANALYSIS PROCESS
JPS4877104A (en) 1972-01-25 1973-10-17
US3837339A (en) 1972-02-03 1974-09-24 Whittaker Corp Blood glucose level monitoring-alarm system and method therefor
DE2205733C3 (en) 1972-02-08 1974-07-18 Boehringer Mannheim Gmbh 9- (gamma-aminopropyl) -3-aminocarbazole
US3814582A (en) 1972-03-02 1974-06-04 Beckman Instruments Inc Automated chemical analyser system
US4059405A (en) 1972-04-11 1977-11-22 Damon Corporation Method and apparatus for analysis of constituent carried in fibrous medium
US3798004A (en) 1972-04-18 1974-03-19 Ames Yissum Ltd Test device
US3769178A (en) 1972-04-27 1973-10-30 Rothermel Ass Inc Method and apparatus for end point detection in potentiometric titration
US3973189A (en) 1972-05-15 1976-08-03 General Science Corporation Hematology system
DE2229208A1 (en) 1972-06-15 1974-01-03 Boehringer Mannheim Gmbh PROCESS FOR SEPARATION OF SUGARS
DE2332760C3 (en) 1972-06-30 1982-03-04 Eastman Kodak Co., 14650 Rochester, N.Y. Material for the quantitative spectrophotometric analysis of a liquid
DE2235152C2 (en) 1972-07-18 1975-07-10 Boehringer Mannheim Gmbh, 6800 Mannheim Diagnostic agent for the detection of blood and other peroxidatically active substances in body fluids
US4180060A (en) 1972-08-18 1979-12-25 Boehringer Mannheim Gmbh Device for staining biological materials
DE2329174C2 (en) 1973-06-07 1975-07-24 Boehringer Mannheim Gmbh, 6800 Mannheim Method for the quantitative determination of blood ammonia
US3902052A (en) 1973-06-11 1975-08-26 Technicon Instr Method and apparatus for the peak monitoring the results of analysis apparatus
US3881992A (en) 1973-07-02 1975-05-06 Wilson Ralston Optical rate measurement method
US3910701A (en) 1973-07-30 1975-10-07 George R Henderson Method and apparatus for measuring light reflectance absorption and or transmission
GB1485508A (en) 1973-07-31 1977-09-14 Olympus Optical Co System for detecting the chemical composition of a fluid
US3975398A (en) 1973-08-01 1976-08-17 Boehringer Mannheim G.M.B.H. 9-Substituted 3-aminocarbazole compounds
US3988208A (en) 1973-08-01 1976-10-26 Boehringer Mannheim G.M.B.H. 9-Substituted 3-aminocarbazole compounds and test strip indicator compositions
US3992158A (en) 1973-08-16 1976-11-16 Eastman Kodak Company Integral analytical element
AR204182A1 (en) 1973-12-20 1975-11-28 Boehringer Mannheim Gmbh TEST STRIP FOR VERIFICATION OF PEROXIDIC ACTIVITY SUBSTANCES IN BODY LIQUIDS
US3907503A (en) 1974-01-21 1975-09-23 Miles Lab Test system
DE2410033C2 (en) 1974-03-02 1975-09-11 Merck Patent Gmbh, 6100 Darmstadt Isolation of substances in aqueous solutions that are soluble in lipophilic solvents
US3876374A (en) 1974-03-22 1975-04-08 Technicon Instr Method and apparatus for automated quantitative fluid analysis
US3983005A (en) 1974-03-25 1976-09-28 Eastman Kodak Company Integral element for the analysis of cholesterol
US3954342A (en) 1974-03-28 1976-05-04 Jan Boeke Optical device for monitoring clarity of a fluid
US3964870A (en) 1974-03-29 1976-06-22 Boehringer Mannheim G.M.B.H. Diagnostic composition for the determination of glucose
US3957436A (en) 1974-04-29 1976-05-18 Kallestad Laboratories, Inc. Resultant color step indicator
US3901657A (en) 1974-04-29 1975-08-26 Sun Scient Inc Device for testing solutions and body fluids
US4283383A (en) 1974-05-20 1981-08-11 Technicon Instruments Corporation Analysis of biological fluids
US4015121A (en) 1974-07-11 1977-03-29 Allca Instruments Co. Ltd. Catalsimeter with time measuring circuitry for determining reactant concentration level
US3919051A (en) 1974-07-11 1975-11-11 Honeywell Inc Biological analyzer and method
DE2436598C2 (en) 1974-07-30 1983-04-07 Boehringer Mannheim Gmbh, 6800 Mannheim Stable test strip for the detection of ingredients in liquids
US3917453A (en) 1974-08-16 1975-11-04 Polaroid Corp Method and device for determining the concentration of a substance in a fluid
US3936357A (en) 1974-08-16 1976-02-03 Polaroid Corporation Method and device for determining the concentration of a substance in a fluid
US3915647A (en) 1974-08-16 1975-10-28 Polaroid Corp Device for determining the concentration of a substance in a fluid
US3926736A (en) 1974-08-30 1975-12-16 Calbiochem Enzymatic ethanol assay
US4014321A (en) 1974-11-25 1977-03-29 March Wayne F Non-invasive glucose sensor system
US3958560A (en) 1974-11-25 1976-05-25 Wayne Front March Non-invasive automatic glucose sensor system
SE7513658L (en) 1974-12-06 1976-06-08 Hycel Inc APPARATUS AND METHOD FOR CALIBRATION OF CHEMICAL ANALYZER
FR2295419A1 (en) 1974-12-21 1976-07-16 Kyoto Daiichi Kagaku Kk REFLECTANCE MEASURING DEVICE AND COMPOSITE TEST PAPER STRUCTURE SUBJECT TO SUCH MEASUREMENT
US3973129A (en) 1975-01-10 1976-08-03 Bell Telephone Laboratories, Incorporated Fluorimetric apparatus and method for analysis of body fluid
US3990849A (en) 1975-02-07 1976-11-09 Technicon Instruments Corporation Separation of cells from liquid components of blood
CA1048390A (en) 1975-02-14 1979-02-13 James B. Dugle Method, composition, and device for determining the specific gravity of a liquid
JPS51114985A (en) 1975-04-01 1976-10-09 Kyoto Daiichi Kagaku:Kk Mothod to analyse urine, etc.
US4040786A (en) 1975-05-16 1977-08-09 Worthington Biochemical Corporation Chemical analysis method using reaction container
CA1054034A (en) 1975-06-20 1979-05-08 Barbara J. Bruschi Multilayer analytical element
US4042335A (en) 1975-07-23 1977-08-16 Eastman Kodak Company Integral element for analysis of liquids
US3960497A (en) 1975-08-19 1976-06-01 Beckman Instruments, Inc. Chemical analyzer with automatic calibration
US3986833A (en) 1975-09-08 1976-10-19 Miles Laboratories, Inc. Test composition, device, and method for the detection of peroxidatively active substances
US3979274A (en) 1975-09-24 1976-09-07 The Yellow Springs Instrument Company, Inc. Membrane for enzyme electrodes
US3971630A (en) 1975-10-07 1976-07-27 Technicon Instruments Corporation Apparatus and method for batch-type analysis of liquid samples
US3985508A (en) 1975-10-28 1976-10-12 Melvin Williams Automated chemical analyzer
US4011046A (en) 1975-11-12 1977-03-08 Temple University Liquid crystal quantitative analysis method for optically active compounds
GB1545538A (en) 1975-11-17 1979-05-10 Gradient Pty Ltd Method and apparatus for simultaneously recording reaction times
US4009615A (en) 1975-12-23 1977-03-01 Ruhl George A Self contained electronic digital thermometer
FR2341865A1 (en) 1976-02-19 1977-09-16 Api Labor SUPPORT FOR THE ASSESSMENT OF ENZYMATIC ACTIVITIES AND METHOD OF ASSESSMENT USING THIS SUPPORT
US4022577A (en) 1976-03-12 1977-05-10 The University Of Virginia Automated radioimmunoassay
US4128628A (en) 1976-03-12 1978-12-05 University Of Virginia Alumni Patents Foundation Automated immunoassay
US4038485A (en) 1976-03-18 1977-07-26 Miles Laboratories, Inc. Test composition, device, and method
US4050898A (en) 1976-04-26 1977-09-27 Eastman Kodak Company Integral analytical element
US4057394A (en) 1976-05-24 1977-11-08 Miles Laboratories, Inc. Test device and method for determining blood hemoglobin
US4101276A (en) 1976-06-02 1978-07-18 Beckman Instruments, Inc. Method and apparatus for signalling the introduction of chemical reaction components into a chemical analyzing system
FR2392378B1 (en) 1976-06-03 1980-10-31 Commissariat Energie Atomique
US4068169A (en) 1976-09-21 1978-01-10 Hycel, Inc. Method and apparatus for determining hematocrit
DE2650730C2 (en) 1976-11-05 1979-03-29 Boehringer Mannheim Gmbh, 6800 Mannheim Submersible dialyzer
US4224032A (en) 1976-12-17 1980-09-23 Eastman Kodak Company Method and apparatus for chemical analysis
US4152390A (en) 1976-12-17 1979-05-01 Eastman Kodak Company Chemical analyzer
US4199261A (en) 1976-12-29 1980-04-22 Smith-Kettlewell Eye Research Foundation Optical intensity meter
US4043756A (en) 1976-12-29 1977-08-23 Hycel, Inc. Calibration in an automatic chemical testing apparatus
US4095272A (en) 1977-01-11 1978-06-13 Phillips Petroleum Company Automatic turbidimetric titration
CA1095819A (en) 1977-01-14 1981-02-17 Eastman Kodak Company Element for analysis of liquids
US4069017A (en) 1977-01-14 1978-01-17 Eastman Kodak Company Colorimetric assay for bilirubin
JPS59779B2 (en) 1977-01-20 1984-01-09 株式会社京都第一科学 Analysis method for urine etc.
US4110079A (en) 1977-06-09 1978-08-29 Eastman Kodak Company Analytical element for clinical analysis
US4098574A (en) 1977-08-01 1978-07-04 Eastman Kodak Company Glucose detection system free from fluoride-ion interference
US4135883A (en) 1977-08-29 1979-01-23 Bio-Dynamics Inc. Blood analyzer system
US4283491A (en) 1977-09-06 1981-08-11 Eastman Kodak Company Analytical elements with improved reagent stability
DE2860548D1 (en) 1977-09-09 1981-04-16 Rank Organisation Ltd An optical sensing instrument
JPS5451893A (en) 1977-09-30 1979-04-24 Sankyo Co Measuring of blood coagulating time
DE2744549C2 (en) 1977-10-04 1984-03-29 Alexander Wiegand Gmbh U. Co Armaturen- U. Manometerfabrik, 8763 Klingenberg Device for monitoring the density of a gas within a pressure vessel
US4298345A (en) 1977-11-21 1981-11-03 Damon Corporation Method and apparatus for chemical spot test analysis
US4178153A (en) 1977-11-21 1979-12-11 Damon Corporation Method and apparatus for chemical spot test analysis
US4219529A (en) 1977-11-28 1980-08-26 Eastman Kodak Company Incubator for chemical analyzer
US4153668A (en) 1978-01-03 1979-05-08 Eastman Kodak Company Multi-zone analytical element and method using same
JPS591977B2 (en) 1978-01-25 1984-01-14 株式会社京都第一科学 Analysis method using color test paper
US4176008A (en) 1978-02-24 1979-11-27 Eastman Kodak Company Method, composition and element for the detection of nitrogen-containing compounds
US4165508A (en) 1978-02-28 1979-08-21 Beckman Instruments, Inc. Method and apparatus for detecting a peak value of an analog signal
FR2420205A1 (en) 1978-03-13 1979-10-12 Videocolor Sa MASK TUBE FOR COLOR TELEVISION
US4226537A (en) 1978-04-15 1980-10-07 Fisons Limited Analytical centrifuge with improved signal/noise ratio
JPS587332Y2 (en) 1978-06-06 1983-02-08 富士写真フイルム株式会社 Multilayer blood chemistry analysis material
US4257862A (en) 1978-07-24 1981-03-24 Eastman Kodak Company Chemical analyzer
DD143379A3 (en) 1978-07-25 1980-08-20 Kallies Karl Heinz INDICATOR TUBES FOR GLUCOSE DETERMINATION
DE2932973A1 (en) 1978-08-14 1980-02-28 Fuji Photo Film Co Ltd INTEGRAL MULTILAYERED MATERIAL FOR CHEMICAL ANALYSIS OF BLOOD
US4199260A (en) 1978-08-21 1980-04-22 Technicon Instruments Corporation Apparatus and method for determining the concentration in a sample
US4250257A (en) 1978-08-24 1981-02-10 Technicon Instruments Corporation Whole blood analyses in porous media
US4230456A (en) 1978-08-30 1980-10-28 Eastman Kodak Company Element and assay for albumin
US4254083A (en) 1979-07-23 1981-03-03 Eastman Kodak Company Structural configuration for transport of a liquid drop through an ingress aperture
US4233029A (en) 1978-10-25 1980-11-11 Eastman Kodak Company Liquid transport device and method
WO1980001081A1 (en) 1978-11-15 1980-05-29 Battelle Memorial Institute Analytical process and means for measuring the amount of hydrogen peroxide in aqueous media and of organic substrates generating hydrogen peroxide by enzymatic oxidation
US4274744A (en) 1978-11-21 1981-06-23 Medico Electronic, Inc. Direct reading digital colorimeter
DE2850603A1 (en) 1978-11-22 1980-06-19 Merck Patent Gmbh HAEMOLYSIS SOLUTION AND METHOD FOR HAEMOLYSING BLOOD
US4211845A (en) 1978-11-24 1980-07-08 Miles Laboratories, Inc. Glucose indicator and method
US4258001A (en) 1978-12-27 1981-03-24 Eastman Kodak Company Element, structure and method for the analysis or transport of liquids
US4273868A (en) 1979-02-23 1981-06-16 Miles Laboratories, Inc. Color stable glucose test
JPS5592698A (en) 1978-12-31 1980-07-14 Kyoto Daiichi Kagaku:Kk Test strip for glucose determination
US4288228A (en) 1979-01-31 1981-09-08 Technicon Instruments Corporation Whole blood analyses and diffusion apparatus therefor
US4274832A (en) 1979-02-12 1981-06-23 Eastman Kodak Company Analytical element and method for analysis of multiple analytes
US4255788A (en) 1979-03-01 1981-03-10 American National Red Cross Phasing detector for continuous flow systems
US4269938A (en) 1979-03-08 1981-05-26 Eastman Kodak Company Assay of peroxidatively active materials
DE2910134A1 (en) 1979-03-15 1980-09-25 Boehringer Mannheim Gmbh DIAGNOSTIC AGENT FOR DETECTING COMPONENTS OF BODY LIQUIDS
US4554132A (en) 1979-03-19 1985-11-19 Cem Corporation Analytical apparatus for determining volatiles, solids, and solvent extractables in a sample
JPS55136957A (en) 1979-04-14 1980-10-25 Olympus Optical Co Ltd Automatic analyzer
JPS55136958A (en) 1979-04-14 1980-10-25 Olympus Optical Co Ltd Automatic analyzer
JPS55164356A (en) 1979-06-08 1980-12-22 Fuji Photo Film Co Ltd Multi-layer analysis sheet for liquid sample analysis
US4272482A (en) 1979-07-02 1981-06-09 Eastman Kodak Company Metering apparatus
US4325910A (en) 1979-07-11 1982-04-20 Technicraft, Inc. Automated multiple-purpose chemical-analysis apparatus
US4310399A (en) 1979-07-23 1982-01-12 Eastman Kodak Company Liquid transport device containing means for delaying capillary flow
US4261041A (en) 1979-08-06 1981-04-07 Medtek Corporation Method and apparatus for controlling a microprocessor-based system
DE2934190A1 (en) 1979-08-23 1981-03-19 Müller, Gerhard, Prof. Dr.-Ing., 7080 Aalen METHOD AND DEVICE FOR MOLECULAR SPECTROSCOPY, ESPECIALLY FOR DETERMINING METABOLISM PRODUCTS
US4310430A (en) 1979-09-11 1982-01-12 Terumo Corporation α-Olefin-dialkylmaleate-based liquid separating agent
US4710458A (en) 1979-09-17 1987-12-01 R. J. Harvey Instrument Corporation Nylon strips for medical assay
US4399099A (en) 1979-09-20 1983-08-16 Buckles Richard G Optical fiber apparatus for quantitative analysis
JPS5647761A (en) 1979-09-27 1981-04-30 Fuji Photo Film Co Ltd Laminated analyzing piece and immunity analyzing method using the same
US4238196A (en) 1979-11-01 1980-12-09 Isolab, Inc. Methods to determine a diagnostic indicator of blood sugar conditions, and, liquid chromatographic columns therefor (cyanide free)
US4318984A (en) 1979-11-13 1982-03-09 Miles Laboratories, Inc. Stabilized composition, test device, and method for detecting the presence of a sugar in a test sample
US4253846A (en) 1979-11-21 1981-03-03 Technicon Instruments Corporation Method and apparatus for automated analysis of fluid samples
US4278439A (en) 1979-12-17 1981-07-14 Miles Laboratories, Inc. Sensitizers for peroxidative activity tests
US4299916A (en) 1979-12-26 1981-11-10 Syva Company Preferential signal production on a surface in immunoassays
US4403984A (en) 1979-12-28 1983-09-13 Biotek, Inc. System for demand-based adminstration of insulin
US4366061A (en) 1980-01-23 1982-12-28 Cordis Dow Corp. Automated diaphragm apparatus and method for controlling negative pressure hemodialysis treatment
US4276051A (en) 1980-01-28 1981-06-30 Coulter Electronics, Inc. System and program for chemical reaction observation with a moving photometer
US4303408A (en) 1980-02-05 1981-12-01 Eastman Kodak Company Removal of interferents in analytical assays in a two phase interferent-removal zone
DE3005923A1 (en) 1980-02-16 1981-09-03 Compur-Electronic GmbH, 8000 München PHOTOMETRIC METHOD AND PHOTOMETRIC DEVICE FOR DETERMINING REACTION PROCESSES
US4303406A (en) 1980-03-14 1981-12-01 The Maytag Company Automatic liquid level control
US4303753A (en) 1980-03-20 1981-12-01 Miles Laboratories, Inc. Method and device for the semiquantitative determination of glucose in aqueous fluids
JPS56155835A (en) 1980-05-02 1981-12-02 Olympus Optical Co Ltd Component analyzing method
GB2079995B (en) 1980-07-16 1984-07-11 Suwa Seikosha Kk Portable data processing apparatus
JPS6033479B2 (en) 1980-07-30 1985-08-02 協和醗酵工業株式会社 Method for quantifying hydrogen peroxide
DE3029579C2 (en) 1980-08-05 1985-12-12 Boehringer Mannheim Gmbh, 6800 Mannheim Method and means for separating plasma or serum from whole blood
US4816224A (en) 1980-08-05 1989-03-28 Boehringer Mannheim Gmbh Device for separating plasma or serum from whole blood and analyzing the same
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US4300906A (en) 1980-10-06 1981-11-17 Technicon Instruments Corp. Method for the operation of automated analysis apparatus
JPS5767860A (en) 1980-10-15 1982-04-24 Fuji Photo Film Co Ltd Material for multilayer analysis
US4407959A (en) 1980-10-29 1983-10-04 Fuji Electric Co., Ltd. Blood sugar analyzing apparatus
US4668619A (en) 1980-10-30 1987-05-26 Miles Laboratories, Inc. Multilayer homogeneous specific binding assay device
US4430427A (en) 1980-11-04 1984-02-07 Phillips Petroleum Company Red absorbing combination of alcohol oxidase and an azide compound
US4420564A (en) 1980-11-21 1983-12-13 Fuji Electric Company, Ltd. Blood sugar analyzer having fixed enzyme membrane sensor
US4483924A (en) 1980-12-09 1984-11-20 Fuji Electric Company, Ltd. System for controlling a printer in a blood sugar analyzer
US4390621A (en) 1980-12-15 1983-06-28 Miles Laboratories, Inc. Method and device for detecting glucose concentration
US4336330A (en) 1980-12-15 1982-06-22 Miles Laboratories, Inc. Device for detecting glucose concentration
JPS57101761A (en) 1980-12-17 1982-06-24 Konishiroku Photo Ind Co Ltd Analyzing element
DE3174918D1 (en) 1980-12-23 1986-08-14 Boehringer Mannheim Gmbh Hydrophilic latex particles, process for their preparation and their use
GB2090659A (en) 1981-01-02 1982-07-14 Instrumentation Labor Inc Analytical device
US4302420A (en) 1981-01-09 1981-11-24 Eastman Kodak Company Analyzer featuring a contacting reflectometer
US4318985A (en) 1981-01-29 1982-03-09 Miles Laboratories, Inc. Method and device for detecting glucose concentration
JPS57125847A (en) 1981-01-30 1982-08-05 Konishiroku Photo Ind Co Ltd Analysis element
US4340669A (en) 1981-02-12 1982-07-20 Miles Laboratories, Inc. System for the determination of glucose in fluids
US4391905A (en) 1981-02-12 1983-07-05 Miles Laboratories, Inc. System for the determination of glucose in fluids
US4391906A (en) 1981-02-12 1983-07-05 Miles Laboratories, Inc. System for the determination of glucose in fluids
JPS57142562A (en) 1981-02-27 1982-09-03 Fuji Photo Film Co Ltd Quantitative analysis film and colorimetric quantitative analysis
US4330299A (en) 1981-03-09 1982-05-18 Evreka, Inc. Article and method for measuring glucose level in body fluids
GB2096314A (en) 1981-03-26 1982-10-13 Lre Relais & Elektronik Gmbh Apparatus for optoelectric evaluation of test paper strips
JPS57174099A (en) 1981-04-17 1982-10-26 Fuji Photo Film Co Ltd Color indicator composition for detecting hydrogen peroxide and quantitative analytical film having reagent layer containing the same
JPS57197466A (en) 1981-04-29 1982-12-03 Konishiroku Photo Ind Co Ltd Analysis element
JPS57196153A (en) 1981-05-28 1982-12-02 Konishiroku Photo Ind Co Ltd Analysis element
JPS57208997A (en) 1981-06-17 1982-12-22 Fuji Photo Film Co Ltd Liquid analyzing material for oxidase enzyme reaction system
US4430299A (en) 1981-06-18 1984-02-07 Coulter Electronics, Inc. Apparatus for monitoring chemical reactions
US4390343A (en) 1981-07-06 1983-06-28 Miles Laboratories, Inc. Multilayer analytical element having an impermeable radiation diffusing and blocking layer
US4595562A (en) 1981-07-20 1986-06-17 American Hospital Supply Corporation Loading and transfer assembly for chemical analyzer
ES275136Y (en) 1981-07-20 1984-10-01 American Hospital Supply Corporation ANCHORING DEVICE FOR PELDANS IN CONCRETE PIECES OR SIMILAR.
JPS5818167A (en) 1981-07-24 1983-02-02 Fuji Photo Film Co Ltd Analyzing film and analysis using said film
US4578248A (en) 1981-07-29 1986-03-25 Nagaoka Kanaami Kabushiki Kaisha Distributor/collector assembly
US4363874A (en) 1981-08-07 1982-12-14 Miles Laboratories, Inc. Multilayer analytical element having an impermeable radiation nondiffusing reflecting layer
US4592365A (en) 1981-08-10 1986-06-03 Ivac Corporation Electronic sphygmomanometer
US4361648A (en) 1981-08-13 1982-11-30 Miles Laboratories, Inc. Color fixed chromogenic analytical element
DE3133826A1 (en) 1981-08-27 1983-03-10 Boehringer Mannheim Gmbh, 6800 Mannheim ANALYSIS TEST STRIP AND METHOD FOR THE PRODUCTION THEREOF
US4420566A (en) 1982-06-10 1983-12-13 Eastman Kodak Company Method and apparatus for detecting sample fluid on an analysis slide
DE3138879A1 (en) 1981-09-30 1983-04-14 Boehringer Mannheim Gmbh, 6800 Mannheim METHOD FOR DETECTING PHOTOMETRIC SIGNALS AND ARRANGEMENT FOR IMPLEMENTING THE METHOD
DE3138878A1 (en) 1981-09-30 1983-04-14 Boehringer Mannheim Gmbh, 6800 Mannheim MEASURING DEVICE, IN PARTICULAR ULBRICHT'S BALL
US4448207A (en) 1981-11-03 1984-05-15 Vital Metrics, Inc. Medical fluid measuring system
JPS5899752A (en) 1981-11-04 1983-06-14 Konishiroku Photo Ind Co Ltd Multi-layer analysis element
US4562148A (en) 1981-11-06 1985-12-31 Miles Laboratories, Inc. Analytical element and method for preventing reagent migration
US4458539A (en) 1981-12-15 1984-07-10 Baxter Travenol Laboratories, Inc. Blood fractionation apparatus having collected volume display system
JPS58131565A (en) 1982-01-14 1983-08-05 Konishiroku Photo Ind Co Ltd Analysing element
US4449538A (en) 1982-01-25 1984-05-22 John Corbitt Medical-electronic body fluid accounting system
JPS58139067A (en) 1982-02-12 1983-08-18 Fuji Photo Film Co Ltd Measurement of liquid sample
US4503555A (en) 1982-04-21 1985-03-05 University Of California Semi-automatic optical scanning apparatus utilizing line integration
US4518259A (en) 1982-07-26 1985-05-21 Eastman Kodak Company Light guide reflectometer
US4460684A (en) 1982-08-02 1984-07-17 Miles Laboratories, Inc. Ascorbate-resistant broad range glucose test composition, test device and method
JPS5926061A (en) 1982-08-02 1984-02-10 Eiken Kagaku Kk Test piece for determining component in bodily fluid
US4499052A (en) 1982-08-30 1985-02-12 Becton, Dickinson And Company Apparatus for distinguishing multiple subpopulations of cells
JP2546981B2 (en) 1982-09-07 1996-10-23 コニカ株式会社 Multilayer analysis element
JPS5946854A (en) 1982-09-10 1984-03-16 Fuji Photo Film Co Ltd Multilayered analytical material
JPS5954962A (en) 1982-09-22 1984-03-29 Fuji Photo Film Co Ltd Multilayer assay material
US4450153A (en) 1982-09-30 1984-05-22 Phillips Petroleum Company Alcohol removal from blood with alcohol oxidase
CA1205731A (en) 1982-11-01 1986-06-10 Roger C. Phillips Test device and method for measurement of analyte levels in colored aqueous fluids
US4478944A (en) 1982-11-24 1984-10-23 Eastman Kodak Company Analytical element containing a barrier zone and process employing same
US4632559A (en) 1982-11-29 1986-12-30 Miles Laboratories, Inc. Optical readhead
US4647432A (en) 1982-11-30 1987-03-03 Japan Tectron Instruments Corporation Tokuyama Soda Kabushiki Kaisha Automatic analysis apparatus
JPS59108942A (en) 1982-12-14 1984-06-23 Fuji Photo Film Co Ltd Determining method using sheet analysis element
CA1237645A (en) 1982-12-21 1988-06-07 John H. Fisher Assay technique
DE3247608A1 (en) 1982-12-23 1984-07-05 Boehringer Mannheim Gmbh, 6800 Mannheim TEST STRIP
US4459358A (en) 1982-12-29 1984-07-10 Polaroid Corporation Multilayer element for analysis
US4587220A (en) 1983-03-28 1986-05-06 Miles Laboratories, Inc. Ascorbate interference-resistant composition, device and method for the determination of peroxidatively active substances
US4649123A (en) 1983-05-12 1987-03-10 Miles Laboratories, Inc. Ion test means having a hydrophilic carrier matrix
DE3321785A1 (en) 1983-06-16 1984-12-20 Boehringer Mannheim Gmbh, 6800 Mannheim DEVICE FOR POSITIONING AND HOLDING A TEST STRIP FOR OPTICAL-MEDICAL MEASUREMENTS
JPS6010171A (en) 1983-06-30 1985-01-19 Fuji Photo Film Co Ltd Multilayer analysis element
US4503385A (en) 1983-07-11 1985-03-05 Becton, Dickinson And Company Apparatus and method for regulating sheath fluid flow in a hydrodynamically focused fluid flow system
US4900666A (en) 1983-07-12 1990-02-13 Lifescan, Inc. Colorimetric ethanol analysis method and test device
US4734360A (en) 1983-07-12 1988-03-29 Lifescan, Inc. Colorimetric ethanol analysis method and test device
US4604579A (en) 1983-07-21 1986-08-05 The Regents Of The University Of California Method and apparatus for enhanced T1 NMR measurements using repetition intervals TR related to one another by integer multiples
JPH0737946B2 (en) 1983-08-05 1995-04-26 株式会社京都第一科学 A device that measures body fluid components and stores and manages test data
US4552458A (en) 1983-10-11 1985-11-12 Eastman Kodak Company Compact reflectometer
US5183741A (en) 1983-10-13 1993-02-02 Fuji Photo Film Co., Ltd. Integral multilayer element for glucose analysis
US4603428A (en) 1983-10-13 1986-07-29 General Electric Company Film-based dual energy radiography
US4637978A (en) 1983-10-28 1987-01-20 Eastman Kodak Company Assay for analysis of whole blood
US4594327A (en) 1983-11-02 1986-06-10 Syntex (U.S.A.) Inc. Assay method for whole blood samples
CA1226796A (en) 1983-11-07 1987-09-15 Anand Kumar Reflective particle-containing analytical element
US4714341A (en) 1984-02-23 1987-12-22 Minolta Camera Kabushiki Kaisha Multi-wavelength oximeter having a means for disregarding a poor signal
US4670218A (en) 1984-02-24 1987-06-02 Miles Laboratories, Inc. Ion test means having a porous carrier matrix
DE3407359A1 (en) 1984-02-29 1985-08-29 Bayer Ag, 5090 Leverkusen TEST DEVICE AND METHOD FOR DETECTING A COMPONENT OF A LIQUID SAMPLE
DE3407754A1 (en) 1984-03-02 1985-09-12 Boehringer Mannheim Gmbh, 6800 Mannheim DEVICE FOR DETERMINING THE DIFFUSION REFLECTIVITY OF A SAMPLE AREA OF SMALL DIMENSIONS
US4532107A (en) 1984-03-26 1985-07-30 Miles Laboratories, Inc. Reagent test device
US4661319A (en) 1984-04-06 1987-04-28 Boehringer Mannheim Diagnostics, Inc. Blood transfer assembly
DD247808C2 (en) 1984-04-09 1989-01-11 Dresden Arzneimittel TEST STRIPS FOR RECEIVING BLOOD SUGAR DAY PROFILES AND METHOD FOR THE PRODUCTION THEREOF
US4627014A (en) 1984-04-09 1986-12-02 Eastman Kodak Company Method and apparatus for determination of an analyte and method of calibrating such apparatus
US4547460A (en) 1984-04-16 1985-10-15 Eastman Kodak Company Multizone analytical element and method for analyte determination
DE3583414D1 (en) 1984-04-27 1991-08-14 Fuji Photo Film Co Ltd COMPONENT OF AN ANALYTICAL ELEMENT FOR ANALYZING A SOLID BODY IN A LIQUID SAMPLE.
DE3587159T2 (en) 1984-04-27 1993-08-19 Fuji Photo Film Co Ltd ANALYTICAL ELEMENT FOR ANALYZING A WHOLE BLOOD SAMPLE.
US4642286A (en) 1984-05-07 1987-02-10 Moldowan Mervin J Composition and method for ethanol determination
CA1259782A (en) 1984-05-23 1989-09-26 Masahiko Yamamoto Butterfly valve
JPS60256443A (en) 1984-05-31 1985-12-18 オムロン株式会社 Image measuring apparatus
US4669878A (en) 1984-06-29 1987-06-02 American Monitor Corporation Automatic monochromator-testing system
CA1260387A (en) 1984-07-17 1989-09-26 Technicon Instruments Corporation Polymeric single layer analytical element
US4693985A (en) 1984-08-21 1987-09-15 Pall Corporation Methods of concentrating ligands and active membranes used therefor
FR2569478B1 (en) 1984-08-23 1987-01-09 Guerin Bernard IMMUNOLOGICAL ANALYSIS STRIP AND METHOD FOR THE PRODUCTION THEREOF
US4876204A (en) 1984-10-11 1989-10-24 Kabushiki Kaisha Kyoto Daiichi Kagaku Method and apparatus of automatic continuous analysis using analytical implement
DE3439181C2 (en) 1984-10-23 1994-01-20 Lange Gmbh Dr Bruno Method for the photometric determination of the concentration of a substance
US4717546A (en) 1984-11-19 1988-01-05 Texas Tech University Health Sciences Center Glucose level measuring apparatus
US5116763A (en) 1984-11-19 1992-05-26 Miles Inc. Nonenzymatic glucose test
GB8429211D0 (en) 1984-11-19 1984-12-27 Mit Peritronic Ltd Reflectometer
US5217691A (en) 1984-11-19 1993-06-08 Miles Inc. Nonenzymatic glucose test
JPS61124393A (en) 1984-11-20 1986-06-12 Konishiroku Photo Ind Co Ltd Analytic element for detection of hydrogen peroxide
JPS61130859A (en) 1984-11-27 1986-06-18 シンテツクス・ダイアグノステイツク・リミテツド・パ−トナ−シツプ Portable analyzer
US4791461A (en) 1984-11-27 1988-12-13 Syntex (U.S.A.) Inc. Portable analyzer
DE3481644D1 (en) 1984-12-10 1990-04-19 Prutec Ltd METHOD FOR THE OPTICAL DETECTION OF PARAMETERS OF SUBSTANCES IN A LIQUID ANALYT.
US4775637A (en) 1984-12-10 1988-10-04 Purtec Limited An immunoassay apparatus having at least two waveguides and method for its use
US4622207A (en) 1984-12-14 1986-11-11 Miles Laboratories, Inc. Reagent test device having sealed matrix boundaries
JPH0673472B2 (en) 1985-02-05 1994-09-21 コニカ株式会社 Analytical element
JPS61212518A (en) 1985-03-19 1986-09-20 Nippon Paint Co Ltd Blood coagulation promoting agent
DE3686184T2 (en) 1985-03-21 1993-02-25 Abbott Lab SPECTRAL PHOTOMETER.
US4787398A (en) 1985-04-08 1988-11-29 Garid, Inc. Glucose medical monitoring system
US4627445A (en) 1985-04-08 1986-12-09 Garid, Inc. Glucose medical monitoring system
US5279294A (en) 1985-04-08 1994-01-18 Cascade Medical, Inc. Medical diagnostic system
GB8509492D0 (en) 1985-04-12 1985-05-15 Plessey Co Plc Optical assay
GB8509491D0 (en) 1985-04-12 1985-05-15 Plessey Co Plc Optic waveguide biosensors
US4602995A (en) 1985-05-20 1986-07-29 Technicon Instruments Corporation Liquid level adjusting and filtering device
US4803159A (en) 1985-06-03 1989-02-07 Eastman Kodak Company Analytical element and method for determination of total lacate dehydrogenase
US4647430A (en) 1985-06-20 1987-03-03 Miles Laboratories, Inc. Volume independent test device
US4686479A (en) 1985-07-22 1987-08-11 Young Chung C Apparatus and control kit for analyzing blood sample values including hematocrit
US4929561A (en) 1985-08-08 1990-05-29 Regents Of The University Of California Absorption-emission optrode and methods of use thereof
US4618475A (en) 1985-08-30 1986-10-21 Miles Laboratories, Inc. Reagent test device containing hydrophobic barriers
US4839296A (en) 1985-10-18 1989-06-13 Chem-Elec, Inc. Blood plasma test method
GB8526355D0 (en) 1985-10-25 1985-11-27 Alta Diagnostic Machines Ltd Determination of antibody content of blood
DE3543416A1 (en) 1985-12-09 1987-06-11 Hoechst Ag METHOD FOR PHOTOMETRICALLY EVALUATING COLOR FIELDS ON TEST STRIPS
US4772561A (en) 1985-12-23 1988-09-20 Miles Inc. Test device and method of determining concentration of a sample component
US4703756A (en) 1986-05-06 1987-11-03 The Regents Of The University Of California Complete glucose monitoring system with an implantable, telemetered sensor module
US4731726A (en) 1986-05-19 1988-03-15 Healthware Corporation Patient-operated glucose monitor and diabetes management system
US4962021A (en) 1986-06-20 1990-10-09 Personal Diagnostics, Inc. Analyte determination using gel including a reagent system reacts with analyte to change transmissive property of gel detectable by light beam transmitted through gel by total internal reflectance
US4981779A (en) 1986-06-26 1991-01-01 Becton, Dickinson And Company Apparatus for monitoring glucose
US4803625A (en) 1986-06-30 1989-02-07 Buddy Systems, Inc. Personal health monitor
US4782511A (en) 1986-07-11 1988-11-01 Murex Corporation Interactive medical laboratory specimen apparatus system
US5029583A (en) 1986-07-22 1991-07-09 Personal Diagnostics, Inc. Optical analyzer
US5049487A (en) 1986-08-13 1991-09-17 Lifescan, Inc. Automated initiation of timing of reflectance readings
US5059394A (en) 1986-08-13 1991-10-22 Lifescan, Inc. Analytical device for the automated determination of analytes in fluids
US4913150A (en) 1986-08-18 1990-04-03 Physio-Control Corporation Method and apparatus for the automatic calibration of signals employed in oximetry
US4790979A (en) 1986-08-29 1988-12-13 Technimed Corporation Test strip and fixture
JPH0672845B2 (en) 1986-09-01 1994-09-14 富士写真フイルム株式会社 Analysis method
CA1317206C (en) 1986-09-22 1993-05-04 Takeyuki Kawaguchi Method for detecting a component of a biological system and detection device and kit therefor
DE3638654A1 (en) 1986-11-12 1988-05-26 Boehringer Mannheim Gmbh TEST CARRIER FOR ANALYTICAL DETERMINATION OF A COMPONENT OF A BODY LIQUID
DE3643516A1 (en) 1986-12-19 1988-06-30 Boehringer Mannheim Gmbh TEST CARRIER FOR THE ANALYTICAL DETERMINATION OF INGREDIENTS OF BODY LIQUIDS
US4970172A (en) 1986-12-22 1990-11-13 Abbott Laboratories Method and device for ketone measurements
US5071769A (en) 1986-12-22 1991-12-10 Abbott Laboratories Method and device for ketone measurement
US4774192A (en) 1987-01-28 1988-09-27 Technimed Corporation A dry reagent delivery system with membrane having porosity gradient
ES2034186T3 (en) 1987-02-17 1993-04-01 Cmb Foodcan Plc ANALYTICAL TESTING DEVICE.
US5047206A (en) 1987-03-11 1991-09-10 Wayne State University Reagent test strip
US4849340A (en) 1987-04-03 1989-07-18 Cardiovascular Diagnostics, Inc. Reaction system element and method for performing prothrombin time assay
US4952515A (en) 1987-05-22 1990-08-28 Polymer Technology International Corp. Method of detection using a test strip having a non particulate dialyzed polymer layer
US5128171A (en) 1987-05-22 1992-07-07 Polymer Technology International Method of making a test strip having a dialyzed polymer layer
US4814142A (en) 1987-05-22 1989-03-21 Polymer Technology International Corp. Test strip having a non-particulate dialyzed polymer layer
US4943522A (en) 1987-06-01 1990-07-24 Quidel Lateral flow, non-bibulous membrane assay protocols
CA1310905C (en) 1987-06-19 1992-12-01 Marvin A. Genshaw Process and device for separating and testing whole blood
US4810470A (en) 1987-06-19 1989-03-07 Miles Inc. Volume independent diagnostic device
US4987085A (en) 1987-06-22 1991-01-22 Chemtrak Inc. Blood filtering metering device
DE3721237A1 (en) 1987-06-27 1989-01-05 Boehringer Mannheim Gmbh DIAGNOSTIC TEST CARRIER AND METHOD FOR THE PRODUCTION THEREOF
US5431880A (en) 1987-07-06 1995-07-11 Kramer; Donald L. Light transmittance type analytical system and variable transmittance optical component and test device for use therein
JPH0191834A (en) 1987-08-20 1989-04-11 Tsuruta Hiroko Abnormal data detection and information method in individual medical data central control system
DE3729079C1 (en) 1987-09-01 1989-02-02 Draegerwerk Ag Colorimetric test tube with pre-treatment area and display area
JPH079069Y2 (en) 1987-11-24 1995-03-06 オムロン株式会社 Reflector for blank value measurement of biochemical measuring instrument
US4909260A (en) 1987-12-03 1990-03-20 American Health Products, Inc. Portable belt monitor of physiological functions and sensors therefor
US4889131A (en) 1987-12-03 1989-12-26 American Health Products, Inc. Portable belt monitor of physiological functions and sensors therefor
US5215716A (en) 1987-12-28 1993-06-01 Fuji Photo Film Co., Ltd. Integral multilayer analytical element
US5079715A (en) 1987-12-28 1992-01-07 Krishnan Venkataraman Electronic data recorder for electric energy metering
JPH0726959B2 (en) 1988-01-20 1995-03-29 富士写真フイルム株式会社 Whole blood analysis element
US5206177A (en) 1988-01-21 1993-04-27 Boehringer Mannheim Corporation Apparatus for determining an analyte and method therefor
US5114673A (en) 1988-01-21 1992-05-19 Boehringer Mannheim Corporaton Apparatus for determination of a component in a sample
GB8801807D0 (en) 1988-01-27 1988-02-24 Amersham Int Plc Biological sensors
US5104793A (en) 1988-02-16 1992-04-14 Boehringer Mannheim Corporation Method for determining an analyte in a liquid sample using a zoned test device and an inhibitor for a label used in said method
US5043269A (en) 1988-02-16 1991-08-27 Spyros Theodoropulos Chromogenic substrate to peroxidase enzymes
US4876207A (en) 1988-02-16 1989-10-24 Eastman Kodak Company Compositions for the detection of high levels of hydrogen peroxide
DE3809523A1 (en) 1988-03-22 1989-10-12 Miles Inc METHOD FOR THE PRODUCTION OF POROESEN MEMBRANES, THE MEMBRANES THEREOF PRODUCED AND THEIR USE AS TRAEGERMATRICES IN TEST STRIPS
NL8800796A (en) 1988-03-29 1989-10-16 X Flow Bv METHOD FOR THE CHEMICAL ANALYSIS OF BODY FLUID COMPONENTS, AND A TESTING DEVICE AND TEST PACKAGE FOR SUCH ANALYSIS.
US4949400A (en) 1988-03-31 1990-08-14 Leveen Harry H Hand held glucose colorimeter device
JPH01253634A (en) 1988-04-01 1989-10-09 Fuji Photo Film Co Ltd Reflection density measuring apparatus
DE3814370A1 (en) 1988-04-28 1989-11-09 Boehringer Mannheim Gmbh TEST PROVIDER FOR THE ANALYSIS OF A SAMPLING FLUID, METHOD FOR CARRYING OUT SUCH ANALYSIS AND METHOD OF PRODUCTION
EP0341928A1 (en) 1988-05-10 1989-11-15 AMERSHAM INTERNATIONAL plc Improvements relating to surface plasmon resonance sensors
GB8811919D0 (en) 1988-05-20 1988-06-22 Amersham Int Plc Biological sensors
GB8813307D0 (en) 1988-06-06 1988-07-13 Amersham Int Plc Biological sensors
ATE148944T1 (en) 1988-06-09 1997-02-15 Boehringer Mannheim Corp TEST DEVICE WITH DEFINED VOLUME
US4994238A (en) 1988-06-09 1991-02-19 Daffern George M Constant volume chemical analysis test device
US4866836A (en) 1988-07-20 1989-09-19 Storage Technology Corporation Method for mounting a magnetic head on a suspension arm
US5152962A (en) 1988-07-22 1992-10-06 Ord Corp. Immunoassay apparatus
US5096809A (en) 1988-07-25 1992-03-17 Pacific Biotech, Inc. Whole blood assays using porous membrane support devices
DE3826057A1 (en) 1988-07-30 1990-02-01 Boehringer Mannheim Gmbh TEST TESTER FOR THE ANALYTICAL DETERMINATION OF AN INGREDIENT OF A LIQUID SAMPLE
US5082626A (en) 1988-08-08 1992-01-21 Boehringer Mannheim Gmbh Wedge shaped test strip system useful in analyzing test samples, such as whole blood
US5171688A (en) 1988-08-30 1992-12-15 Cholestech Corporation Self-corrected assay device
EP0361489A3 (en) 1988-09-30 1991-06-12 Chugai Seiyaku Kabushiki Kaisha Novel 3,4-diaminoquinoline and pyridine compounds
JPH0721455B2 (en) 1988-12-01 1995-03-08 株式会社京都第一科学 Tools and Methods for Analyzing Specific Components in Liquid Samples
US5079174A (en) 1988-12-08 1992-01-07 Boehringer Mannheim Corporation Apparatus for sequential determination of an analyte in a fluid sample
US5106758A (en) 1988-12-12 1992-04-21 Technicon Instruments Corporation Analytical test device and the use thereof
DE3844104A1 (en) 1988-12-28 1990-07-05 Boehringer Mannheim Gmbh TEST CARRIER ANALYSIS SYSTEM
US5252293A (en) 1989-01-17 1993-10-12 Vladimir Drbal Analytical slide with porous filter membrane
US5114350A (en) 1989-03-08 1992-05-19 Cholestech Corporation Controlled-volume assay apparatus
SE466157B (en) 1989-04-25 1992-01-07 Migrata Uk Ltd DETERMINED TO DETERMINE THE GLUCOSE CONTENT OF WHOLE BLOOD AND DISPOSABLE BEFORE THIS
DE3921391A1 (en) 1989-06-29 1991-01-10 Lre Relais & Elektronik Gmbh DEVICE FOR REMISSION-PHOTOMETRIC ANALYSIS OF LIQUID SAMPLES
DE3922495A1 (en) 1989-07-08 1991-01-17 Miles Inc ANALYSIS METHOD FOR SUBSTANCES FROM BIOLOGICAL FLUIDS, IN PARTICULAR FULLBLOOD
US5149505A (en) 1989-07-18 1992-09-22 Abbott Laboratories Diagnostic testing device
US4976724A (en) 1989-08-25 1990-12-11 Lifescan, Inc. Lancet ejector mechanism
US5306623A (en) 1989-08-28 1994-04-26 Lifescan, Inc. Visual blood glucose concentration test strip
US5620863A (en) 1989-08-28 1997-04-15 Lifescan, Inc. Blood glucose strip having reduced side reactions
AU640162B2 (en) 1989-08-28 1993-08-19 Lifescan, Inc. Blood separation and analyte detection techniques
JPH0395435A (en) 1989-09-08 1991-04-19 Terumo Corp Measuring apparatus
AU635314B2 (en) 1989-09-08 1993-03-18 Terumo Kabushiki Kaisha Measuring apparatus
US5467475A (en) 1989-10-13 1995-11-14 Hitachi Maxell, Ltd. Data collection-transmission apparatus and data collection system
US5036852A (en) 1989-12-08 1991-08-06 Leishman Mark L Medical equipment monitor apparatus and method
US5207263A (en) 1989-12-26 1993-05-04 Bp America Inc. VLS silicon carbide whisker reinforced metal matrix composites
US5188968A (en) 1989-12-28 1993-02-23 Olympus Optical Co., Ltd. Method and reaction kit for agglutination detection
JP2618727B2 (en) 1990-01-19 1997-06-11 富士写真フイルム株式会社 Method for quantifying test components in whole blood
US5104619A (en) 1990-01-24 1992-04-14 Gds Technology, Inc. Disposable diagnostic system
US5067093A (en) 1990-01-24 1991-11-19 Eastman Kodak Company Reference reading in an analyzer
DE4005021A1 (en) 1990-02-19 1991-08-22 Boehringer Mannheim Gmbh TEST CARRIER FOR ANALYSIS OF A SAMPLING LIQUID
JPH03280930A (en) 1990-03-29 1991-12-11 Aisin Seiki Co Ltd Informing device for medical information
US5110724A (en) 1990-04-02 1992-05-05 Cholestech Corporation Multi-analyte assay device
US5046619A (en) 1990-04-05 1991-09-10 Hwang Feng Lin Mini-package structure of rubbish bags
DE4012216A1 (en) 1990-04-14 1991-10-17 Boehringer Mannheim Gmbh TEST CARRIER FOR THE ANALYSIS OF LIQUIDS
US5212060A (en) 1990-04-27 1993-05-18 Genesis Labs, Inc. Dry test strip comprising a dextran barrier for excluding erythrocytes
DE4015590A1 (en) 1990-05-15 1991-11-21 Boehringer Mannheim Gmbh TEST CARRIER FOR THE DETERMINATION OF IONS
US5321618A (en) 1990-05-29 1994-06-14 Lawrence Gessman Apparatus and method for remotely monitoring implanted cardioverter defibrillators
US5187100A (en) 1990-05-29 1993-02-16 Lifescan, Inc. Dispersion to limit penetration of aqueous solutions into a membrane
US5225997A (en) 1990-06-05 1993-07-06 Sygnus Controls Inc. Automatic monitoring and remote reporting device
US5147606A (en) 1990-08-06 1992-09-15 Miles Inc. Self-metering fluid analysis device
US5166051A (en) 1990-08-08 1992-11-24 Genesis Labs, Inc. Membranes, membrane overlays for exclusion of erythrocytes, and method for immunoassay of whole blood analytes
US5251126A (en) 1990-10-29 1993-10-05 Miles Inc. Diabetes data analysis and interpretation method
US5237472A (en) 1990-12-19 1993-08-17 Integral Peripherals, Inc. Rigid disk drive with dynamic head loading apparatus
DE4041905A1 (en) 1990-12-27 1992-07-02 Boehringer Mannheim Gmbh TEST CARRIER ANALYSIS SYSTEM
AU661466C (en) 1991-01-03 2001-10-11 Sasktel Data collection network apparatus and method
US5246858A (en) 1991-02-27 1993-09-21 Boehringer Mannheim Corporation Apparatus and method for analyzing a body fluid
EP0576536B1 (en) 1991-02-27 2001-12-12 Roche Diagnostics Corporation Method of communicating with microcomputer controlled instruments
JPH04324347A (en) 1991-04-24 1992-11-13 Terumo Corp Testing device
US5666404A (en) 1991-07-31 1997-09-09 Manfred Asrican Device for telephone monitoring of patients having peripheral arterial occlusive disease
US5371020A (en) 1991-09-19 1994-12-06 Radiometer A/S Method of photometric in vitro determination of the content of an analyte in a sample
US5179288A (en) * 1991-09-30 1993-01-12 Ortho Pharmaceutical Corporation Apparatus and method for measuring a bodily constituent
EP0555045B1 (en) 1992-02-03 1997-10-08 Lifescan, Inc. Improved oxidative coupling dye for spectrophotometric quantitative analysis of analytes
JPH08275927A (en) 1992-02-13 1996-10-22 Seta:Kk Homestay medical care system and medical device used in this system
US5296192A (en) * 1992-04-03 1994-03-22 Home Diagnostics, Inc. Diagnostic test strip
GR1002549B (en) 1992-05-12 1997-01-28 Lifescan Inc. Fluid conducting test strip with Transport Medium
US5390238A (en) 1992-06-15 1995-02-14 Motorola, Inc. Health support system
US5424545A (en) 1992-07-15 1995-06-13 Myron J. Block Non-invasive non-spectrophotometric infrared measurement of blood analyte concentrations
US5321492A (en) 1992-08-07 1994-06-14 Miles Inc. Dual function readhead for a reflectance instrument
US5581369A (en) 1992-09-25 1996-12-03 Ralin, Inc. Apparatus and method for communicating electrocardiographic data to a facsimile machine
US5302348A (en) 1992-12-10 1994-04-12 Itc Corporation Blood coagulation time test apparatus and method
US5344754A (en) 1993-01-13 1994-09-06 Avocet Medical, Inc. Assay timed by electrical resistance change and test strip
DE4301524A1 (en) 1993-01-21 1994-07-28 Jostra Medizintechnik Medical unit or device for operating theaters, in particular heart-lung machine
US5416695A (en) 1993-03-09 1995-05-16 Metriplex, Inc. Method and apparatus for alerting patients and medical personnel of emergency medical situations
US5576952A (en) 1993-03-09 1996-11-19 Metriplex, Inc. Medical alert distribution system with selective filtering of medical information
DE4310583A1 (en) 1993-03-31 1994-10-06 Boehringer Mannheim Gmbh Test strip analysis system
US5843691A (en) 1993-05-15 1998-12-01 Lifescan, Inc. Visually-readable reagent test strip
US5837546A (en) 1993-08-24 1998-11-17 Metrika, Inc. Electronic assay device and method
US5770389A (en) 1993-09-27 1998-06-23 Abbott Laboratories Apparatus and method for determining the quanity of an analyte in a biological sample by means of transmission photometry
US5529755A (en) 1994-02-22 1996-06-25 Minolta Co., Ltd. Apparatus for measuring a glucose concentration
US5704366A (en) 1994-05-23 1998-01-06 Enact Health Management Systems System for monitoring and reporting medical measurements
US5545877A (en) 1994-06-02 1996-08-13 Shelton; David B. Cooking vessel with water detection means
US6319665B1 (en) 1994-06-07 2001-11-20 Inverness Medical Technology, Inc. Home test kit and method with telephone verification of results
US5452343A (en) 1994-06-28 1995-09-19 At&T Corp. Telemetry access arrangement
US5470752A (en) 1994-06-29 1995-11-28 Lxn Corporation Multi-layer devices and methods of assaying for fructosamine
CA2156226C (en) 1994-08-25 1999-02-23 Takayuki Taguchi Biological fluid analyzing device and method
US5462051A (en) 1994-08-31 1995-10-31 Colin Corporation Medical communication system
US5922530A (en) 1994-09-08 1999-07-13 Lifescan, Inc. Stable coupling dye for photometric determination of analytes
US5515170A (en) 1994-09-08 1996-05-07 Lifescan, Inc. Analyte detection device having a serpentine passageway for indicator strips
US5526120A (en) 1994-09-08 1996-06-11 Lifescan, Inc. Test strip with an asymmetrical end insuring correct insertion for measuring
US5579001A (en) 1994-10-20 1996-11-26 Hewlett-Packard Co. Paging-based backchannel in a medical telemetry system
US5579775A (en) 1994-10-20 1996-12-03 Hewlett-Packard Company Dynamic control of a patient monitoring system
US5597532A (en) 1994-10-20 1997-01-28 Connolly; James Apparatus for determining substances contained in a body fluid
US5605150A (en) 1994-11-04 1997-02-25 Physio-Control Corporation Electrical interface for a portable electronic physiological instrument having separable components
US5827180A (en) 1994-11-07 1998-10-27 Lifemasters Supported Selfcare Method and apparatus for a personal health network
US5585069A (en) 1994-11-10 1996-12-17 David Sarnoff Research Center, Inc. Partitioned microelectronic and fluidic device array for clinical diagnostics and chemical synthesis
US5728352A (en) 1994-11-14 1998-03-17 Advanced Care Products Disposable electronic diagnostic instrument
US5573506A (en) 1994-11-25 1996-11-12 Block Medical, Inc. Remotely programmable infusion system
US5593426A (en) 1994-12-07 1997-01-14 Heartstream, Inc. Defibrillator system using multiple external defibrillators and a communications network
AU706456B2 (en) 1995-03-27 1999-06-17 Lifescan, Inc. Chemical timer for a direct-reading reagent test strip
US5719034A (en) 1995-03-27 1998-02-17 Lifescan, Inc. Chemical timer for a visual test strip
US5725774A (en) 1995-04-07 1998-03-10 Lxn Corp. Whole blood separation method and devices using the same
US5695949A (en) 1995-04-07 1997-12-09 Lxn Corp. Combined assay for current glucose level and intermediate or long-term glycemic control
US5842975A (en) 1995-06-07 1998-12-01 Illyes; Miklos Controlling and data accumulating device attachable to human biologic measuring device
US5758644A (en) 1995-06-07 1998-06-02 Masimo Corporation Manual and automatic probe calibration
NZ299104A (en) 1995-08-03 1998-04-27 Lifescan Inc Reagent test strip
JPH0947436A (en) 1995-08-09 1997-02-18 Noboru Akasaka Home medical system
US5518689A (en) 1995-09-05 1996-05-21 Bayer Corporation Diffused light reflectance readhead
US5754111A (en) 1995-09-20 1998-05-19 Garcia; Alfredo Medical alerting system
US5639672A (en) 1995-10-16 1997-06-17 Lxn Corporation Electrochemical determination of fructosamine
AU722471B2 (en) 1995-10-17 2000-08-03 Lifescan, Inc. Blood glucose strip having reduced sensitivity to hematocrit
US5704364A (en) 1995-11-08 1998-01-06 Instromedix, Inc. Concurrent medical patient data and voice communication method and apparatus
US5764158A (en) 1995-11-20 1998-06-09 Water Savers, Inc. Meter reading data transmissiion system and method of using same
US5738828A (en) * 1996-01-16 1998-04-14 Umm Electronics Inc. Apparatus for detecting proper strip insertion into an optical reflectance meter
FI960636A (en) 1996-02-12 1997-08-13 Nokia Mobile Phones Ltd A procedure for monitoring the health of a patient
FI118509B (en) 1996-02-12 2007-12-14 Nokia Oyj A method and apparatus for predicting blood glucose levels in a patient
US5989917A (en) 1996-02-13 1999-11-23 Selfcare, Inc. Glucose monitor and test strip containers for use in same
US5605837A (en) 1996-02-14 1997-02-25 Lifescan, Inc. Control solution for a blood glucose monitor
US5715823A (en) 1996-02-27 1998-02-10 Atlantis Diagnostics International, L.L.C. Ultrasonic diagnostic imaging system with universal access to diagnostic information and images
US5753452A (en) * 1996-04-04 1998-05-19 Lifescan, Inc. Reagent test strip for blood glucose determination
IL120587A (en) 1996-04-04 2000-10-31 Lifescan Inc Reagent test strip for determination of blood glucose
US5962215A (en) 1996-04-05 1999-10-05 Mercury Diagnostics, Inc. Methods for testing the concentration of an analyte in a body fluid
US5735285A (en) 1996-06-04 1998-04-07 Data Critical Corp. Method and hand-held apparatus for demodulating and viewing frequency modulated biomedical signals
US5770839A (en) 1996-06-20 1998-06-23 Union Camp Corporation Microwaveable bag for cooking and serving food
US5872627A (en) 1996-07-30 1999-02-16 Bayer Corporation Method and apparatus for detecting scattered light in an analytical instrument
US5745308A (en) 1996-07-30 1998-04-28 Bayer Corporation Methods and apparatus for an optical illuminator assembly and its alignment
US5772963A (en) 1996-07-30 1998-06-30 Bayer Corporation Analytical instrument having a control area network and distributed logic nodes
US5753429A (en) 1996-08-09 1998-05-19 Lifescan, Inc. Analyte concentration measurement using a hollow frustum
US5736103A (en) 1996-08-09 1998-04-07 Lifescan, Inc. Remote-dosing analyte concentration meter
US5846486A (en) 1996-08-09 1998-12-08 Lifescan, Inc. Hollow frustum reagent test device
US5791342A (en) 1996-09-03 1998-08-11 Telediagnostics Systems, Inc. Medical data transmission system
US5841846A (en) 1996-09-16 1998-11-24 American Telecare, Inc. Digital telephonic system for stethoscope signal processing
US5714123A (en) 1996-09-30 1998-02-03 Lifescan, Inc. Protective shield for a blood glucose strip
US5885839A (en) * 1997-04-15 1999-03-23 Lxn Corporation Methods of determining initiation and variable end points for measuring a chemical reaction
US5850320A (en) 1997-05-13 1998-12-15 Seagate Technology, Inc. Head-gimbal assembly with reduced vertical spacing envelope and alignment structures
US6168957B1 (en) 1997-06-25 2001-01-02 Lifescan, Inc. Diagnostic test strip having on-strip calibration
HU222809B1 (en) * 1997-10-03 2003-10-28 77 Elektronika Műszeripari Kft. Method and apparatus for detecting chemical component from sample mostly for detecting glucose content of blood from blood sample
US5997817A (en) 1997-12-05 1999-12-07 Roche Diagnostics Corporation Electrochemical biosensor test strip
US5986754A (en) 1997-12-08 1999-11-16 Lifescan, Inc. Medical diagnostic apparatus using a Fresnel reflector
US6069011A (en) * 1997-12-10 2000-05-30 Umm Electronics, Inc. Method for determining the application of a sample fluid on an analyte strip using first and second derivatives
US5995236A (en) 1998-04-13 1999-11-30 Mit Development Corporation Blood fluid characteristics analysis instrument
PT1077636E (en) 1998-05-13 2004-06-30 Cygnus Therapeutic Systems SIGNAL PROCESSING FOR PHYSIOLOGICAL ANALYZES MEDICATION
US6226082B1 (en) 1998-06-25 2001-05-01 Amira Medical Method and apparatus for the quantitative analysis of a liquid sample with surface enhanced spectroscopy
US6521182B1 (en) 1998-07-20 2003-02-18 Lifescan, Inc. Fluidic device for medical diagnostics
US6084660A (en) 1998-07-20 2000-07-04 Lifescan, Inc. Initiation of an analytical measurement in blood
JP4070050B2 (en) * 1998-07-24 2008-04-02 テルモ株式会社 Blood glucose level measuring method and apparatus
US6067463A (en) 1999-01-05 2000-05-23 Abbott Laboratories Method and apparatus for non-invasively measuring the amount of glucose in blood
US6150124A (en) * 1999-05-20 2000-11-21 Umm Electronics, Inc. Method for passively determining the application of a sample fluid on an analyte strip
US6193873B1 (en) 1999-06-15 2001-02-27 Lifescan, Inc. Sample detection to initiate timing of an electrochemical assay

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1983000926A1 (en) * 1981-08-28 1983-03-17 Clark, Stanley Reflectance meter
US5843692A (en) * 1986-08-13 1998-12-01 Lifescan, Inc. Automatic initiation of a time interval for measuring glucose concentration in a sample of whole blood
US5968760A (en) * 1986-08-13 1999-10-19 Lifescan, Inc. Temperature-Independent Blood Glucose Measurement
US5277870A (en) * 1991-01-07 1994-01-11 United Medical Manufacturing Company Blood glucose reflectance meter including a null prompting means and a device for providing a constant brightness light
US5780304A (en) * 1994-09-08 1998-07-14 Lifescan, Inc. Method and apparatus for analyte detection having on-strip standard
US6040195A (en) * 1997-06-10 2000-03-21 Home Diagnostics, Inc. Diagnostic sanitary test strip
US6088608A (en) * 1997-10-20 2000-07-11 Alfred E. Mann Foundation Electrochemical sensor and integrity tests therefor
US6136610A (en) * 1998-11-23 2000-10-24 Praxsys Biosystems, Inc. Method and apparatus for performing a lateral flow assay
WO2001038859A1 (en) * 1999-11-24 2001-05-31 Home Diagnostics, Inc. Protective test strip platform for optical meter apparatus
US20020019707A1 (en) * 2000-06-26 2002-02-14 Cohen Alan M. Glucose metering system

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP1364042A4 *

Cited By (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8551308B2 (en) 1999-10-04 2013-10-08 Roche Diagnostics Operations, Inc. Biosensor and method of making
US8287703B2 (en) 1999-10-04 2012-10-16 Roche Diagnostics Operations, Inc. Biosensor and method of making
EP1452854A4 (en) * 2001-11-20 2010-02-17 Arkray Inc Fail judging method for analysis and analyzer
EP1452854A1 (en) * 2001-11-20 2004-09-01 Arkray, Inc. Fail judging method for analysis and analyzer
US7829023B2 (en) 2003-06-20 2010-11-09 Roche Diagnostics Operations, Inc. Test strip with vent opening
US8298828B2 (en) 2003-06-20 2012-10-30 Roche Diagnostics Operations, Inc. System and method for determining the concentration of an analyte in a sample fluid
US7718439B2 (en) 2003-06-20 2010-05-18 Roche Diagnostics Operations, Inc. System and method for coding information on a biosensor test strip
US7727467B2 (en) 2003-06-20 2010-06-01 Roche Diagnostics Operations, Inc. Reagent stripe for test strip
US7749437B2 (en) 2003-06-20 2010-07-06 Roche Diagnostics Operations, Inc. Method and reagent for producing narrow, homogenous reagent stripes
US7645373B2 (en) 2003-06-20 2010-01-12 Roche Diagnostic Operations, Inc. System and method for coding information on a biosensor test strip
US7879618B2 (en) 2003-06-20 2011-02-01 Roche Diagnostics Operations, Inc. Method and reagent for producing narrow, homogenous reagent strips
US8058077B2 (en) 2003-06-20 2011-11-15 Roche Diagnostics Operations, Inc. Method for coding information on a biosensor test strip
US8071030B2 (en) 2003-06-20 2011-12-06 Roche Diagnostics Operations, Inc. Test strip with flared sample receiving chamber
US8119414B2 (en) 2003-06-20 2012-02-21 Roche Diagnostics Operations, Inc. Test strip with slot vent opening
US8142721B2 (en) 2003-06-20 2012-03-27 Roche Diagnostics Operations, Inc. Test strip with slot vent opening
US8206565B2 (en) 2003-06-20 2012-06-26 Roche Diagnostics Operation, Inc. System and method for coding information on a biosensor test strip
US8211379B2 (en) 2003-06-20 2012-07-03 Roche Diagnostics Operations, Inc. Test strip with slot vent opening
US8222044B2 (en) 2003-06-20 2012-07-17 Roche Diagnostics Operations, Inc. Test strip with flared sample receiving chamber
US8663442B2 (en) 2003-06-20 2014-03-04 Roche Diagnostics Operations, Inc. System and method for analyte measurement using dose sufficiency electrodes
US7645421B2 (en) 2003-06-20 2010-01-12 Roche Diagnostics Operations, Inc. System and method for coding information on a biosensor test strip
US8507289B1 (en) 2003-06-20 2013-08-13 Roche Diagnostics Operations, Inc. System and method for coding information on a biosensor test strip
US8586373B2 (en) 2003-06-20 2013-11-19 Roche Diagnostics Operations, Inc. System and method for determining the concentration of an analyte in a sample fluid
US9410915B2 (en) 2004-06-18 2016-08-09 Roche Operations Ltd. System and method for quality assurance of a biosensor test strip
WO2008017819A1 (en) * 2006-08-08 2008-02-14 Ivmd (Uk) Limited Assay apparatus, assay reading apparatus and method
US8548935B2 (en) 2008-02-14 2013-10-01 Orion Diagnostica Oy Predicting a future property using reagents by measuring properties at points in time
WO2009101242A1 (en) * 2008-02-14 2009-08-20 Orion Diagnostica Oy Method for predicting a future property
US9885712B2 (en) 2012-11-15 2018-02-06 Ortho-Clinical Diagnostics, Inc. Calibrating assays using reaction time
US11287424B2 (en) 2012-11-15 2022-03-29 Ortho-Clinical Diagnostics, Inc. Calibrating assays using reaction time
WO2018077863A1 (en) * 2016-10-25 2018-05-03 Roche Diabetes Care Gmbh Method for determination of an analyte concentration in a body fluid and analyte concentration measurement device
KR20190053258A (en) * 2016-10-25 2019-05-17 에프. 호프만-라 로슈 아게 Method and method for determining analyte concentration of body fluid
CN109922730A (en) * 2016-10-25 2019-06-21 豪夫迈·罗氏有限公司 For determining the method and analyte concentration measurement equipment of the analyte concentration in body fluid
KR102252241B1 (en) 2016-10-25 2021-05-14 에프. 호프만-라 로슈 아게 Method for determining analyte concentration in body fluid and device for measuring analyte concentration
CN109922730B (en) * 2016-10-25 2022-03-22 豪夫迈·罗氏有限公司 Method for determining an analyte concentration in a body fluid and analyte concentration measuring device
EP3315069A1 (en) * 2016-10-25 2018-05-02 Roche Diabetes Care GmbH Method for determination of an analyte concentration in a body fluid and analyte concentration measurement device
US11284817B2 (en) 2016-10-25 2022-03-29 Roche Diabetes Care, Inc. Method for determination of an analyte concentration in a body fluid and analyte concentration measurement device
JP7141392B2 (en) 2016-10-25 2022-09-22 エフ ホフマン-ラ ロッシュ アクチェン ゲゼルシャフト Method and device for determining analyte concentration in body fluids

Also Published As

Publication number Publication date
US6541266B2 (en) 2003-04-01
EP1364042A4 (en) 2005-03-30
US20020146835A1 (en) 2002-10-10
EP1364042A1 (en) 2003-11-26

Similar Documents

Publication Publication Date Title
US6541266B2 (en) Method for determining concentration of an analyte in a test strip
US6525330B2 (en) Method of strip insertion detection
US6562625B2 (en) Distinguishing test types through spectral analysis
EP0471986B1 (en) Quantitative analysis method and its system using a disposable sensor
JP6448504B2 (en) Slope-based correction
US5885839A (en) Methods of determining initiation and variable end points for measuring a chemical reaction
US20060099703A1 (en) Device for quantitative analysis of biological materials
US20080248581A1 (en) Method for performing correction of blood glucose assay bias using blood hemoglobin concentration
AU2004229538A2 (en) Dual measurement analyte detection system
WO1996013707A9 (en) Apparatus and method for determining substances contained in a body fluid
JPH0734758B2 (en) Whole blood glucose determination method and cuvette and photometer for performing the method
JP2011506966A5 (en)
AU1449699A (en) Reflectometer
EP0750739A1 (en) Apparatus and method for determining substances contained in a body fluid
EP0283285A2 (en) Method and apparatus for monitoring analytes in fluids
WO1999035487A1 (en) Methods and apparatus for accurate analysis of bodily fluid constituents
CA2926287C (en) Method and device for determining a concentration of an analyte in a bodily fluid
KR100911927B1 (en) Device for analyzing quantitatively material of living creature
KR101090947B1 (en) Test strip and living creature analyzing device and analyzing method using it

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2002709363

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2002709363

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP